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ABSTRACT 
 
The outbreak of the highly pathogenic avian influenza virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. The turkey 
industry was the most affected as nearly 70% of the confirmed cases were in turkeys. 
This project examined viral distribution, semi-quantitative viral load, histological viral 
lesions, and gene expression of several immune components in 8 tissues of naturally 
infected turkey breeder hens during the outbreak. Tissues from clinically and sub-
clinically affected turkeys, as well as negative controls were obtained: brain, heart, GI, 
liver, lung, reproductive tract, spleen, and trachea.  Changes in the gene expression of 
IL-1β, IL-6, IL-10, CCL-5, CXCLi-2, Mx, OASL, IFN-γ, IFIH1, FasL and TRAIL were 
described. 
 
The matrix gene was detected in all 8 of the tissues collected from the clinical 
and sub-clinical groups. The clinically affected turkeys had significantly higher levels of 
matrix gene detected in the brain, GI, spleen, and trachea. Histological viral lesions were 
in general very mild and insignificant. The majority of the histological changes were 
confined to the trachea and liver and primarily consisted of the infiltration of small 
numbers of heterophils, lymphocytes, and macrophages. This particular virus was able to 
evade the host’s immune response using several tactics. It was able to avoid initial 
detection by suppressing IFIH1 expression, the pro-inflammatory cytokines IL-1β and 
IL-6, and the antiviral component IFN-γ in the trachea. Undetected, the virus quickly 
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disseminated throughout the body and replicated rapidly.  The widespread 
downregulation of IFN-γ and upregulation of CCL-5 and OASL likely contributed to the 
pathogenesis.  
 
Virus was detected in all of the tissues collected on the positive premise, 
regardless of clinical status thus illustrating its extreme infectivity. Generally, 
histological lesions were minimal and cytokine responses were not excessive. Death 
does not appear to be the result of organ damage/necrosis or even cytokine storm, but 
purely from immune evasion and excessive viral load in the tissues. Consequently the 
high viral loads in the tissues resulted in organ failure. 
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CHAPTER I  
INTRODUCTION/LITERATURE REVIEW  
 
History of Highly Pathogenic Avian Influenza 
Highly Pathogenic Avian Influenza, formerly termed ‘fowl plague’, was first 
described in chickens in Italy by Perroncito in 1878 (Kaleta and Rulke, 2008). Although 
the disease quickly spread through Europe thereafter, it wasn’t until 1901 that the 
disease was determined to be caused by a virus. The virus was not identified or classified 
until 1955. There have been 19 HPAI outbreaks worldwide since its classification, with 
the majority occurring in Europe and Asia (Swayne and Suarez, 2000; Swayne, 2008). 
The phrase ‘highly pathogenic avian influenza’ was coined in 1981 at the first 
International Symposium on Avian Influenza (Swayne and Suarez, 2000). Since then, 
there has been an intense international effort led by the Office International des 
Epizooties (OIE) and the Food and Agricultural Organization of the United Nations 
(FAO) to control and quickly eradicate the disease when necessary. Full eradication is 
not possible, since wild birds harbor and spread the virus. The United States’ stringent 
‘stamping-out’ policy for controlling HPAI contains the disease but results in significant 
direct and indirect loses to the industry and consumers via flock depopulation, disposal, 
quarantine, and cleaning and disinfection of infected flocks and premises (USDA-
APHIS, 2015).  
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Prior to the outbreak of HPAI in the spring of 2015, there were three large HPAI 
outbreaks and a handful of smaller HPAI cases in the United States. The first outbreak of 
HPAI occurred in the fall and winter 1924-1925. The disease spread rapidly from live 
bird markets to other regions with the movement of infected birds and contaminated 
equipment (Lupiani and Reddy, 2009). Restrictions on the movement of live poultry and 
stringent quarantine, depopulation, and cleaning and disinfecting procedures controlled 
the outbreak and eradicated the disease from the United States (Lupiani and Reddy, 
2009). The second HPAI outbreak in the United States was a result of an LPAI strain of 
H5N2 mutating into an HPAI strain. The outbreak was isolated to the northeastern states 
in 1983-1984 and involved more than 17 million birds (Lupiani and Reddy, 2009). The 
third HPAI outbreak occurred in a chicken flock in the southern United States in 2004 
but was quickly eradicated (USDA, 2015).   
 
Due to the deadly potential of AI, certain strains are notifiable to the World 
Organisation for Animal Health, formerly known as the OIE. The OIE is an international 
organization that sets the sanitary and health standards of animals that safeguards 
international trade. The OIE defines a reportable virus as “any influenza A virus of the 
H5 or H7 subtypes or by any AI virus with an intravenous pathogenicity index (IVPI) 
greater than 1.2 (or as an alternative at least 75% mortality)” (OIE, 2015). Highly 
pathogenic avian influenza has been known to arise from LPAI H5 or H7 subtypes, 
therefore making it reportable.  The OIE categorizes HPAI as a List A disease. List A 
diseases are defined as “transmissible diseases that have the potential for very serious 
 3 
 
and rapid spread, irrespective of national borders, that are of serious socio-economic or 
public health consequence and that are of major importance in the international trade of 
animals and animal products” (OIE, 2015). According to the Centers for Disease Control 
and Prevention (2015), over 700 human cases of HPAI have been reported to the World 
Health Organization since 2003. Countries take the threat of AI very seriously, and act 
accordingly. International trade of all poultry in the affected nation is shut down during 
an outbreak. Vaccination for HPAI can mask the disease as it only reduces the morbidity 
and mortality as opposed to preventing the shedding and transmission of the disease. 
Infected poultry or poultry products can be unknowingly traded. Therefore, controlling 
HPAI via vaccination has international export and trade implications (USDA-APHIS, 
2015).  
 
Even though vaccinating for HPAI can have export and trade sanctions, it can be 
an important tool when it comes to containing and controlling the disease (OIE, 2006). 
This is of particular importance in regions of the world such as South East Asia, where 
HPAI has become uncontrollable and endemic to the region (Eagles et al., 2009). In 
South East Asia, the poultry industry is far less industrialized than in the United States. 
Village chickens, free range duck production, live bird markets, and the uncontrolled 
movement of poultry are common (FAO, 2016). Biosecurity is often times very minimal 
and through the frequent interaction between wild and domestic birds, particularly 
ducks, HPAI has undergone reassortment and is now circulating in the wild bird 
populations (FAO, 2016). 
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H5N2 Outbreak of 2014-2015 
The outbreak of the Highly Pathogenic Avian Influenza Virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. Genetic 
analysis of the virus revealed that it was a combination of an HPAI in Asia and an LPAI 
of American lineage. The Asian strain was most likely introduced into North America 
via Alaska in 2014. Birds from the two continents comingle during the summer months 
before migrating back south for the winter (USDA-APHIS, 2015). The fall migration 
brought the virus down the West Coast via the Pacific Flyway to the wintering grounds 
that those birds shared with birds from the Central and Mississippi Flyways. It was then 
spread throughout the central United States during the 2015 spring migration (USDA-
APHIS, 2015).    
 
The H5N2 virus was first detected on December 19, 2014 in a backyard poultry 
flock in Douglas County, Oregon (USDA-APHIS, 2015). The virus was sporadically 
detected on the West Coast in less than a dozen backyard and commercial chicken flocks 
during the months of January and February of 2015. The disease was first detected in 
Minnesota in Pope County on March 4, 2015 and spread rapidly thereafter. Out of 211 
commercial flocks infected, 185 occurred in the upper Midwest during the months of 
April and May in 2015. The deadly virus was last detected on June 17, 2015 in a 
commercial layer flock in Wright County, Iowa (UDSA-APHIS, 2015). Within six 
months of its first detection, HPAI H5N2 destroyed nearly 50 million birds in 21 states, 
making it the largest animal disease outbreak in United States history (UDSA-APHIS, 
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2015). It devastated the egg laying and turkey industries in the upper Midwest and cost 
the government over $950 million to contain the disease. 
  
Once an HPAI positive premise was identified/confirmed using rRT-PCR of 
tracheal swabs, a 3-km ‘infected zone’, a 7-km ‘buffer zone’ and a 10- km ‘control area’ 
perimeter was set up from the infected premise (USDA-APHIS, 2015). A USDA 
Incident Commander was put in charge of each infected premise. Flocks in the control 
area were tested daily using tracheal swabs for HPAI via PCR. Flocks outside the 
Control Area, but still considered to be at risk, were tested on a weekly basis. Movement 
within or out of a control area required a USDA permit (USDA-APHIS, 2015). This 
included poults, eggs, semen, feed, and any equipment. Each infected premise was to be 
depopulated within 24 hours of testing positive for HPAI. Due to the magnitude of the 
outbreak and lack of preparedness, resources and personnel were insufficient to deal 
with the situation. In some cases, it took days or weeks to depopulate flocks, which 
allowed the disease to spread even further. Once a flock was depopulated and composted 
properly, the premise could be cleaned and disinfected and tested. A premise could begin 
restocking efforts 21 days after a negative HPAI test.  
 
Etiology 
Avian influenza (AI) viruses are part of the Orthomyxoviridae family and genus 
Influenzavirus. It is an enveloped, spherical to pleomorphic shaped virion ranging in size 
from 80-120nm. The entire viral genome is enclosed in a helical nucleocapsid which 
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consists of eight single-stranded, negative sense, ribonucleic acid (RNA) segments 
(Suarez, 2008; Adam and Sandrock, 2010). The surface is covered with two types of 
glycoprotein projections, viral antigens; the rod-shaped trimer hemagglutinin (HA) 
responsible for recognizing and binding sialic acid receptors of target cells and the 
mushroom shaped tetramer neuraminidase (NA) that cleaves sialic acid from HA to 
release virons from infected cells (Vasin et al., 2014). There are 16 HA antigenic strain 
classifications based on haemagglutination-inhibition (HI) and 9 NA antigenic strain 
classifications based on neuraminidase-inhibition (NI) (Suarez, 2008).  
 
In addition to the surface proteins, there is a membrane ion-channel protein (M2) 
that helps to acidify the viron and three internal proteins: the nucleoprotein (NP), the 
matrix protein (M1), and the polymerase complex (Vasin et al., 2014). Lastly, there are 
two nonstructural proteins (NS), NS1 and NS2. The NS1 protein works to evade the 
host’s immune response by inhibiting interferon production (Krug, 2015) and 
suppressing Fas/Fas-ligand-mediated apoptosis (Xing et al., 2009). The NS2 protein 
exports the virus and regulates influenza RNA levels (Vasin et al., 2014). The NP tightly 
binds the RNA segments and forms the ribonucleoprotein (RNP) core (Adam and 
Sandrock, 2010). The M1 protein encodes the main component of the viral capsid. The 
polymerase complex aids in viral transcription and is composed of the polymerase basic 
protein 1 (PB1), polymerase basic protein 2 (PB2), and polymerase acidic protein (PA) 
(Vasin et al., 2014). 
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 The virus is relatively unstable and susceptible to inactivation through heat, 
extreme pH, drying, organic solvents, and detergents (Saif, 2003). Organic material such 
as nasal secretions or feces can protect the fairly fragile virus in the environment for an 
extended period of time (Saif, 2003). The rate of inactivation depends on the size and 
composition of droplets surrounding the virus (Sooryanarain and Elankumaran, 2015). 
Persistence in the environmental is largely dependent upon temperature; cool-dry or 
cool-moist conditions favor virus survivability and transmissibility (Sooryanarain and 
Elankumaran, 2015). The virus was shown to survive in liquid manure for 105 days in 
the cool winter months (Saif, 2003).  
 
All AI viruses are Type A influenza viruses and infect a large variety of hosts 
including birds, pigs, and humans. Types B and C typically do not cause diseases in 
poultry. Domestic fowl are not considered to be natural hosts of the virus, but typically 
become readily infected. Waterfowl and shore birds of the orders Anseriformes and 
Charadriformes are natural, asymptomatic, infectious reservoirs (Stallknecht and Brown, 
2008; Cardona et al., 2009). In addition, they harbor all HA and NA viral gene 
combinations (Cardona et al., 2009). The virus is ubiquitous. Viral presence or anti-AI 
antibodies have been found on all seven continents in wild fowl (Saif, 2003). Infection in 
waterfowl typically results in an asymptomatic enteric infection and spreads primarily 
via the feces into the environment (Cardona et al., 2009).  The virus can be transmitted 
via direct contact as well as indirect contact via aerosol droplets and contaminated 
fomites (Saif, 2003). Influenza viruses of low pathogenicity in wild birds can easily 
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mutate and reassort within the wild bird populations to produce other LPAI subtypes 
(Zhao el al., 2012). An HPAI typically arises from infections of LPAI of the H5 and H7 
serotypes circulating in domestic fowl (Zhao el al., 2012). In particular, AI viruses of 
duck origin have been shown to rapidly adapt to chickens and emerge quickly (Li et al., 
2009). Bird migration and air movements may contribute to environmental transmission 
(Sooryanarain and Elankumaran, 2015).  
 
Once in poultry, the virus can spread rapidly via feces and nasal secretions 
(Swayne and Suarez, 2000) and contaminated materials (Horimoto and Kawaoka, 2005). 
Airborne dissemination appears to play a major role during outbreaks. Dust from wind 
storms during China’s spring 2005 outbreak of HPAI was shown to have facilitated the 
spread of the disease (Liu et al., 2007). The HPAI virus can also be found in high 
concentrations in the semen of infected sub-clinical turkey breeder toms (Wileman, 
2015). Experimental inoculations via the oviduct during insemination of the turkey 
breeder hen resulted in AI infections (Pantin-Jackwood et al., 2010). This potential route 
of transmission is of great importance to the turkey breeder industry which typically 
inseminates breeder hens weekly (Pantin-Jackwood et al., 2010). 
 
The primary and most important difference between LPAI and HPAI is found in 
the HA cleavage sites. When the virus attaches to the sialic acid receptor of the host cell, 
receptor mediated endocytosis is initiated (Swayne and Pantin-Jackwood, 2008). Once 
inside, viral RNA is released into the cytoplasm and viral replication and assembly 
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within the host’s cells begins. The HA precursor molecule (HA0) undergoes post-
translational proteolytic cleavage via host proteases into HA1 and HA2 subunits 
(Horimoto and Kawaoka, 2005). The viral envelope and the endosomal membrane 
become fused during this process, making the virion infectious. The virus is 
noninfectious until cleaved. Low pathogenic avian influenza viruses possess a single 
arginine at the cleavage site with an amino acid sequence of RETR (Horimoto and 
Kawaoka, 2005). This sequence can only be cleaved by trypsin-like proteases found in 
the respiratory and digestive tracts (Suarez, 2008), therefore limiting the number of cells 
it can effectively replicate in. The HPAI viruses have cleavage sites between arginine 
and glycine (Post et al., 2012) and a series of basic amino acids at the cleavage site, 
RERRRKKR (Horimoto and Kawaoka, 2005), that can be cleaved by ubiquitous 
proteases found in most tissues making systemic viral replication possible (Post et al., 
2012). An LPAI can be converted into an HPAI with the simple insertion of two to ten 
basic amino acids at the cleavage site (Post et al., 2012).  
 
Host Defenses 
Viral Sensing  
The innate immune response is the bird’s first line of defense against microbes. It 
consists of both physical and chemical barriers such as skin, tight epithelial lining of the 
GI tract, tears, and mucosal secretions as well as non-specific immune cells such as 
phagocytes and natural killer cells (Abbas et al., 2007). In birds there are two main 
pattern recognition receptors (PRR) that are important in recognizing viral pathogen-
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associated molecular patterns (PAMPs) and activating macrophages: toll-like receptors 
(TLR) and retinoic acid-inducible gene I (RIG-I)-like receptors (RLR) (Chen et al., 
2013).  Several TLRs recognize viral PAMPs: TLR2, TLR3, TLR4, and TLR7 
(Brownlie and Allan, 2011; Chen et al., 2013; Keestra et al., 2013). More importantly, 
TLR3 and TLR7 are key in recognizing HPAI viruses (Chen et al., 2013) and inducing 
antiviral responses in macrophages (Barjesteh et al., 2014). The TLRs are type-I integral 
transmembrane glycoprotein signaling receptors that play an important role in the innate 
immune response to pathogens (Chen et al., 2013; Keestra et al., 2013). They consist of 
three domains: the N-terminal domain which consists of leucine and cysteine rich 
regions, the transmembrane domain, and the intracellular Toll/IL-1 receptor domain 
(Brownlie and Allan, 2011). The TLRs recruit adapter proteins, protein kinases, and they 
activate gene transcription (Keestra et al., 2013). The activation of macrophages and 
subsequent downstream signaling of the PRRs leads to the expression of several innate 
antiviral cytokines and chemokines (Chen et al., 2013).  
 
There are two RLRs: RIG-I and melanoma differentiation-associated gene 5 
(MDA5). They contain five domains: two N-terminal caspase activation and recruitment 
domains, an RNA helicase domain, a C-terminal RNA-binding domain and a repressor 
domain (Chen et al., 2013). The RLRs are cytoplasmic sensors that bind viral RNA. 
They employ a signaling cascade that stimulates the expression of antiviral type-I 
interferons (Chen et al., 2013) to signal natural killer cells to destroy the infected cell 
(Abbas et al., 2007). Chickens and turkeys, unlike ducks, lack the RIG-I receptor. Both 
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RIG-I and MDA5 are important in sensing influenza virus in birds. The MDA5 is said to 
have similar functions as RIG-I (Chen et al., 2013). The interferon–induced helicase 
domain-containing protein 1 (IFIH1) gene encodes for MDA5.  
 
There are two types of T-cells, CD4+ T-helper and CD8+ T- cytotoxic, that are 
activated via the T-cell receptor complex following virus recognition and co-stimulation 
(Abbas, 2007). Upon antigenic stimulation, naïve T-helper (Th) cells differentiate into 
subsets including T-helper 1 (Th1) and T-helper 2 (Th2) (Zhang et al., 2003). Th1 cells 
secrete cytokines such as IFN-γ and tend to promote cellular immunity while Th2 cells 
secrete another set of cytokines to down-regulate Th1 responses and support humoral 
immunity (Zhang et al., 2003). Viral antigen can also be presented by the MHC I 
associated antigen presenting cell to naïve CD8+ T-cells and assist with the lysing of 
infected cells. (Abbas, 2007).   
 
Cytokines  
Cytokines are peptides that are secreted to mediate cellular responses associated 
with the innate and adaptive immune systems (Kaiser et al. 2004). Via complex 
networks, these molecules send chemical signals throughout the body to initiate and 
control the host’s response to pathogens whether it be a pro-inflammatory or anti-
inflammatory reaction (Kogut, 2000). Cytokines direct the host’s immune response 
towards cell-mediated or antibody-mediated responses by means of promoting or 
suppressing the proliferation of various immune cells (Kapczynski et al., 2014).  
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Pro-Inflammatory Cytokines 
Interleukin-1β, a pro-inflammatory cytokine produced by macrophages, 
endothelial cells, and epithelial cells, mediates the inflammatory response of the host.  
The level of response or inflammation depends on the amount of IL-1β produced.  Small 
quantities result in local inflammation.  When large concentrations of IL-1β enter the 
blood stream, the synthesis of acute phase plasma proteins and the production of IL-6 are 
stimulated (Abbas et al., 2007). An increase in the production of chemokines and 
corticosterone can also be seen in response to elevated levels of IL-1β (Hilton et al., 
2002).  
 
Interleukin-6 is a multifunctional cytokine that is involved in hematopoiesis, 
immune regulation, and acute phase response (Gupta et al., 2015). As a pro-
inflammatory cytokine (Kapczynski et al., 2014), it promotes the growth of B-
lymphocytes (Abbas et al., 2007). It is produced by T- and B-lymphocytes, endothelial 
cells, fibroblasts, and monocytes (Gupta et al., 2015).  
 
Anti-Inflammatory Cytokines 
Anti-inflammatory cytokines are immuno-regulatory molecules that control the 
pro-inflammatory cytokine responses (Opal and DePalo, 2000). One of the most 
important immuno-regulatory cytokines, IL-10, is secreted by activated macrophages 
and T-regulatory cells (Opal and DePalo, 2000). It helps maintain the balance between 
the innate and cell mediated immune responses by inhibiting activated macrophages 
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(Abbas et al., 2007) and inflammation (Kaiser et al., 2004). Interleukin-10 is a potent 
IFN-γ inhibitor (Opal and DePalo, 2000). In addition to its pro-inflammatory properties 
previously mentioned, IL-6 has anti-inflammatory properties, inhibiting IFN-γ 
production (Opal and DePalo, 2000).  
 
Chemokines  
Chemokines are a large family of small cytokines that stimulate and regulate 
leukocyte movement from the blood into the infected tissues, also known as chemotaxis 
(Abbas et al., 2007). They are highly specific secondary pro-inflammatory mediators 
(Graves and Jiang 1995). There are two major chemokine families, CC and CXC, that 
are classified based on their cysteine residues (Abbas et al., 2007). The CXC family, also 
known as α-chemokines, have various amino acids separating the cysteine residues while 
the CC motif or β-cytokines do not (Graves and Jiang 1995). Chemokine are produced 
by numerous cell types and their secretion is triggered via TLR signaling or by 
inflammatory cytokines (Abbas et al., 2007). The C-C motif ligand 5 (CCL-5) is 
involved in mixed leukocyte recruitment. The C-X-C motif ligand 8, known as CXCLi-2 
in avian species, is involved in neutrophil recruitment. This ligand was formerly termed 
as IL-8 (Abbas et al., 2007).  
 
Anti-Viral Cytokines 
Interferons (IFN) are multifunctional glycoproteins that are known for their anti-
viral properties (Gupta et al., 2015). They are produced by white blood cells in response 
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to viral infections as well as virally infected somatic cells (Kogut, 2000). There are three 
types of IFNs but only two of which are characterized in the bird: Type I and Type II. 
Type I IFNs, IFN-α, are produced by virally infected monocytes and fibroblasts (Gupta 
et al., 2015) and are important in controlling intracellular infections (Davidson et al., 
2008). IFN-γ, a Type II interferon, is produced by the T-lymphocytes and natural killer 
cells following stimulation (Gupta et al., 2015). IFN-γ controls the cell-mediated 
immune response and serves as a major activator of macrophages (Gupta et al., 2015).  
 
The Myxovirus-resistance (Mx) and 2’5’-oligoadenylate sythetase (OAS) are 
IFN stimulated genes and are considered to be some of the most effective antiviral 
proteins produced by the host cell (Ewald et al., 2011). The Mx gene blocks viral 
transcription into the nucleus (Iwasaki and Pillai, 2014). The OAS family of antiviral 
proteins consists of four genes: OAS1, OAS2, OAS3, and OASL (Kristiansen et al., 
2010). These antiviral proteins are responsible for the activation of RNase L which 
initiates the degradation of viral RNA in infected cells and limits viral propagation (Lee 
et al., 2013 and Iwasaki and Pillai, 2014).  Further, OAS1 and OASL have been shown 
to inhibit the translation of the interferon-inducible master transcription factor of type I 
interferon (IRF7), thus down regulating the production of type-I interferons during viral 
infections and preventing tissue damage from a hyper-inflammatory response (Lee et al., 
2013).   
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Apoptosis/Induced Cell Death 
Apoptosis or induced cell death can be initiated via intrinsic or extrinsic 
pathways. Interaction of the death ligands, FasL (CD95L) and tumor necrosis factor 
(TNF) - related apoptosis-inducing ligand (TRAIL), with their specific receptor initiates 
the extrinsic apoptotic pathway (Ekchariyawat et al., 2011). Initiation of the pathway 
results in the recruitment of Fas-associated death domain containing protein (FADD) and 
caspase-8 to the death inducing signaling complex which then initiates the apoptosis 
executing caspase cascade (Ekchariyawat et al., 2011).  Both TRAIL and Fas are critical 
in modulating lymphocyte apoptosis and immune function (Waring and Mullbacher, 
1999). The H5N1 virus has been shown to evade the host’s immune response by 
inducing the cell death of lymphocytes, dendritic cells, and monocytes thus allowing it to 
move beyond the respiratory tract and cause blood-borne systemic infections 
(Ekchariyawat et al., 2011). Specifically TRAIL has been shown to induce apoptosis of 
infected monocyte derived macrophages with H5N1 infections (Ekchariyawat et al., 
2011). The ability of the virus to induce apoptosis of the immune cells may contribute to 
its pathogenesis. Activation induced cell death of the T-cells is mediated by the Fas/FasL 
pathway (Waring and Mullbacher, 1999).  FasL is expressed on T-cells, B-cells, 
macrophages, and natural killer cells and its expression is upregulated with T-cell 
activation (Waring and Mullbacher, 1999). Blocking the expression of either TRAIL or 
Fas results in a significant enhancement of IFN-γ production (Zhang et al., 2003). 
Expression of Fas is associated mainly with Th1 cell apoptosis while the activation and 
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induced expression of TRAIL occurs mainly with Th2 cell apoptosis (Roberts, et al., 
2003).  
 
Cytokine and Apoptotic Response to AI  
The host’s cytokine response to AIs can be characterized via gene expression 
profiling using rRT-PCR (Kapczynski et al., 2014). Understanding, comparing, and 
contrasting how hosts respond to particular pathogens may pave the way to novel 
prevention and treatment technology. For example, asymptomatic infected individuals 
are not quiescent and responded immunologically very different than symptomatic 
individuals when experimentally infected with influenza (McClain et al., 2015). 
Asymptomatic individuals tend to have an early and persistent down regulation of 
inflammatory mediators (McClain et al., 2015). The expression of inflammatory 
mediators, as well as other immune related components can be accurately quantified and 
profiled using reverse transcribed mRNA extracted from biological samples and real 
time quantitative-reverse transcription-PCR (qRT-PCR) (Roth, 2002). Sequence specific 
primers are used to target specific genes, amplify, and then measure them (Roth, 2002). 
In order to calculate changes in gene expression, highly conserved endogenous 
housekeeping genes, commonly glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
are used as internal controls (Zhou et al., 2010). The cycle at which the reporter dye 
fluorescence increases beyond a defined threshold is known as the cycle threshold (Ct). 
Results are reported as actual Ct values. Changes in gene expression can be expressed as 
fold changes using the described 2-ΔΔ Ct method (Livak and Schmittgen 2001). 
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Immune Evasion 
Even with a highly evolved and complex immune system in the host, AI viruses 
are still able to evade it. Virulence can be correlated with immune evasion (Perdue, 
2008; Swayne and Suarez, 2000). Avian influenza viruses use several tactics to elude the 
immune system. The virus is known for its high mutability and reassortment capabilities 
(Perdue, 2008; Swayne and Suarez, 2000). Mutating or reassorting changes the 
specificity of the antibody needed for host protection, thus resulting in increased viral 
replication and transmission of mutated strains (Hale et al., 2010). Immunoglobulin (Ig)-
M is produced approximately five days post infection followed by production of IgY. 
The antibodies produced recognize specific subtypes of AI and do not provide cross 
protection (Suarez and Schultz-Cherry, 2000).  
 
The NS viral proteins are critical in immune evasion. The NS1 protein can limit 
the production and effectiveness of the interferons that inhibit viral replication, (Hale et 
al., 2010) by blocking the cytoplasmic RIG-I/MDA5 signaling cascade or by attenuating 
INF-inducible signaling (Hale et al., 2010 and Vijayakumar et al., 2015). The protein 
can suppress the Fas/Fas-ligand-mediated apoptosis thus increasing the infectivity (Xing 
et al., 2009). Together with the virus polymerase complex, NS contributes to cytokine 
hyperinduction (Mok et al., 2009).  
 
In general, the virus can induce and or inhibit cellular apoptosis of various cell 
types including immune cells (Ekchariyawat et al., 2011), increase viral replication 
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speed (Hale et al., 2010) and induce cytokine deregulation of the host (Kuribayashi et 
al., 2013). The extracellular signal-regulated kinase 1/2, which is important for viral 
replication, has been shown to interfere with the host’s pro-inflammatory and apoptotic 
responses (Xing et al., 2010). Efficient viral replication, coupled with the destruction of 
the innate immune response, increases pathogenicity (Suzuki et al., 2009). The HPAI 
strain A/Turkey/Ontario/7732/66 has been shown to destroy lymphocytes both in vitro 
and in vivo (Suarez and Schultz-Cherry, 2000). The ability to evade the host’s immune 
system and subsequent pathogenicity varies greatly and is highly dependent upon the 
individual virus (Cardona et al., 2008).  
 
Immunopathology  
Depending on the species and individual virus involved, infections with AI can 
be low to moderately pathogenic, with birds exhibiting sub-clinical to mild infection, to 
highly pathogenic and cause close to 100% mortality (Swayne and Pantin-Jackwood, 
2008). Individual variation in immune response has been noted in humans and several 
species of birds following experimental infection (McClain et al., 2015; Hayashi et al., 
2011). Specific pathological and histological lesions are highly dependent upon the 
individual virus itself (Cardona et al., 2008; Kuribayashi et al., 2013), the inoculum 
dose, and the route of exposure (Saif, 2003). For example, the HPAI 
A/turkey/Italy4580/1999 replicated more extensively in the brain of experimentally 
inoculated chickens as opposed to the chicken/Netherlands/2586/2003 H7N7 strain 
(Kuribayashi et al., 2013).  
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Cytokines are essential in clearing viral infections, but in large quantities or 
unregulated they can result in hypercytokinemia or “cytokine storms” and cause 
significant tissue damage or even death in the host (Kuribayashi et al., 2013). Cytokine 
storms occur when large amounts of pro-inflammatory interleukins and interferons are 
released into circulation as a result of the rapid proliferation and over production of 
highly activated T-cells and natural killer cells (Kuribayashi et al., 2013). Enhanced 
activation of the dendritic cells, in the chicken, following an HPAI infection may lead to 
the deregulation of the immune response, making the virus highly pathogenic (Vervelde, 
et al., 2013). Excessive levels of pro-inflammatory cytokines can trigger bleeding, 
clotting, and subsequent organ/tissue damage and necrosis (Kuribayashi et al., 2013). It 
can lead to fatal systemic capillary leakage in chickens infected with HPAI (Kuribayashi 
et al., 2013). IL-1β and Il-6 are believed to be partially responsible for the induced 
pathology in infections with AI (Burggraaf et al., 2014).  
 
Clinical signs are often times a result of viral replication and consequent tissue 
damage to the visceral organs and the cardiovascular and nervous systems (Saif, 2003). 
Tissue damage can be caused by actual virus replication or cytokine production (Saif, 
2003).  High mortality prior to the onset of clinical signs can be seen with HPAIs due to 
its ability to replicate rapidly and to quickly become systemic (Saif, 2003). Although 
there is variability with regards to site and extent of the lesions between strains of HPAI 
(Mo et al., 1997), the most prevalent histological lesions associated with HPAIs are 
multi-organ necrosis and inflammation of the brain, heart, pancreas, and lymphoid 
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organs (Saif, 2003).  The virus quickly attacks both the vascular endothelial cells and 
perivascular tissue cells leading to swelling of the microvascular endothelium, systemic 
congestion, perivascular mononuclear cell infiltration, multifocal hemorrhages, and 
thrombosis (Kobayashi et al., 2007). Lesions are typically associated with viral antigen 
presence in the cells. In severe cases of HPAI, viral antigen can be found in tissues in the 
absence of lesions (Hagag et al., 2015). Virus can be found in multiple organs following 
infections with HPAIs including the lung (Hayashi et al., 2011; Mo et al., 1997), kidney 
(Hayashi et al., 2011; Mo et al., 1997), pancreas (Mo et al., 1997), spleen, liver (Hayashi 
et al., 2011), cardiac myocytes (Kobayashi et al., 2007), and in the neuron and glial cells 
of the brain (Hayashi et al., 2011). Viral antigen was detected between the seminiferous 
tubules and on the heads of the sperm inside in naturally infected chickens (Hagag et al., 
2015). Rapid virus replication in the macrophages and vascular endothelial cells leads to 
the destruction of thermoregulation and the innate immune system (Suzuki et al., 2009). 
 
Ducks 
In general, ducks are typically asymptomatic and have a very strong antiviral 
response and weak/moderate pro-inflammatory response to infections with AI viruses 
(Adams et al., 2009). Ducks exhibit a down regulation of MHC II resulting in a less 
robust antibody response (Adams et al., 2009) and subsequently the lowest antibody titer 
when compared to other species challenged with AI (Suarez and Schultz-Cherry, 2000). 
The PRR RIG-I response is present in the duck. It detects RNA ligands derived from 
uncapped viral transcripts and initiates antiviral pathways. Expression of RIG-I has been 
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shown to increase as much as 200 fold when challenged with H5N1, thus linking RIG-I 
to the early antiviral innate immune response (Barber et al., 2010). Additionally, TLR3 
is down-regulated in the lungs of the duck when challenged with HPAI (Chen et al., 
2013). Ducks express a very different pattern of the interferon-induced transmembrane 
protein (IFITM) genes and cytokines when compared to the chicken (Smith et al., 2015).  
There is a marked decrease in the production of interferons and a strong up regulation of 
IFITM 1, 2, and 3 as well as anti-inflammatory cytokines in ducks infected with HPAI. 
Recently, the importance of the IFITM-3 and its antiviral activity against AI viruses in 
the duck (Blyth et al., 2016) were described, further reiterating its significance in AI 
infections. Furthermore, ducks exhibit a slow induction of IL-6 and the acute phase 
protein serum amyloid A compared to the rapid upregulation in chickens (Burggraaf et 
al., 2014). Inoculated duck lung cells showed little change in the signal transducer and 
activator of transcription-3 (Kuchipudi et al., 2014). 
 
Another unique host mechanism, and potential protective strategy, is the ability 
of infected cells to undergo rapid death thus limiting viral replication (Kuchipudi et al., 
2012). Duck cells experimentally infected with a HPAI H5N1, that was non-fatal to 
ducks, underwent rapid cell death as opposed to a very slow cell death observed with the 
Eurasian H5N2 known to be fatal (Kuchipudi et al., 2012). Rapid apoptosis of infected 
cells typically occurs before viral replication and assembly are completed, thus limiting 
its replication. The dead cells then undergo subsequent phagocytosis and the virus is 
 22 
 
cleared from the host (Kuchipudi et al., 2012). This mechanism has not been described 
in other species.   
 
Chickens 
Chickens appear to have a rapid, systemic, and often fatal reaction following 
infections with HPAIs that typically consist of high viral loads, extensive tissue damage, 
and an intense activation of the innate immune response (Burggraaf et al., 2014).  High 
pro-inflammatory cytokine levels tend to coincide with the presence of lesions in 
chickens (Adams et al., 2009). Chickens also tend to produce very high antibody titers in 
response to an infection (Suarez and Schultz-Cherry, 2000). The PRR RIG-I is absent in 
the chicken and believed to partially explain the increased susceptibility to infection 
(Barber et al., 2010). Chickens appear to have very little IFITM response as well when 
compared to ducks (Smith et al., 2015). Susceptibility also appears to have a genetic 
component. Some variants of the Mx gene do not produce antiviral activity whereas 
other variants do. Chickens expressing the Asn631 allele of the Mx proteins had 
increased antiviral activity and were more resistant to infection than those expressing the 
Ser631 allele that does not encode for antiviral activity (Ewald et al., 2011). 
 
Experimental studies in the chicken regarding viral replication and subsequent 
innate immune response have contributed to the overall understanding of AIs. Although 
wide ranges of cytokine response has been reported (Adams et al., 2009), trends have 
developed.  Intranasally inoculated chickens with HPAI H7N1 induced a significant 
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increase in IFN-γ, IL-1β, IL-6, and IFN-α in proportion to the virus proliferation in the 
brain, lungs, heart, kidney, spleen, and colon (Kuribayashi et al., 2013). Early death in 
chickens infected with HPAI H5N1 was associated with the upregulation of IFN-α, IFN-
γ, and Mx1 as well as increased viral replication in the lungs and spleens (Wasilenko et 
al., 2009). A significant increase in CXCLi-2, IFN-α, IFN-γ, TLR1, TRL3 and TLR-21 
following experimental challenge of chickens with HPAI H7N2 and H5N2 has been 
demonstrated (Vervelde et al., in 2013). ). Strong induction of IL-6, IL-12, and IFNs are 
found in the lung and spleen of chickens infected with HPAI H5N1 (Vervelde et al., in 
2013). Levels produced were dependent upon viral strains (Vervelde et al., in 2013). The 
signal transducer and activator of transcription (STAT)-3, which is responsible for 
mediating the pro-inflammatory response, was found to be down-regulated and IL-6, 
CXCLi-2, and IL-10 were highly upregulated in chickens lung cells experimentally 
infected with HPAI H5N1 (Kuchipudi et al., 2014).  
 
There have been large differences in viral RNA concentrations and host gene 
expression noted between chickens infected with HPAI or LPAI in the brain (Post, et al., 
2012). Viral RNA can be found throughout the body but replication in the brain and 
subsequent apoptosis of the HPAI infected brain cells appears to be the most remarkable 
differences between HPAI and LPAI in chickens (Post, et al., 2012). Viral RNA and 
antigen were detected in all tissues in naturally infected broilers with HPAI H5N1 in 
Egypt, with the highest levels seen in the brain and trachea (Hagag, et al., 2015). 
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Excessive cytokine response has led to fatal systemic capillary leakage particularly in 
the brain of chickens infected HPAIs (Kuribayashi et al., 2013). 
 
There is only one document which examines the reproductive tract response of 
egg laying hens infected with AI, however it is with an LPAI.  Hens experimentally 
infected with H9N2 resulted in significant tissue damage and apoptosis in all segments 
of the oviduct (Wang et al., 2015). In addition, gene expression of TLR3, MDA5, IL-2, 
IFN-β, CXCLi1, CXCLi2, XCL1, XCR1, and CCR5 were shown to fluctuate across 
regions and throughout the course of the infection (Wang et al., 2015). It is unknown if 
this response is similar to the infection seen with HPAIs.   
 
Pigeons 
Following the experimental inoculation of pigeons with HPAI H5N1, viral RNA 
was recovered from the lungs, spleen, brain, liver, kidneys, and rectum of the birds 
(Hayashi et al., 2011). Lesions were occasionally produced in the brain but varied by 
individual and ranged from no observable lesions to severe encephalitis (Hayashi et al., 
2011). Viral load in the brains was correlated with the level of IL-6 and IL-1B 
expression in the brain (Hayashi et al., 2011).  
 
Turkeys 
While the host’s immune response to avian influenza has been described in 
mammals and to an extent in the chicken and duck (Blyth et al., 2016; Cardona et al., 
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2008; Kuchipudi et al., 2012; and Swayne, 2008), there are less than a handful of articles 
documenting the immune response in the turkey. All of which describe experimental 
inoculations with LPAIs and have been published within the last three years (Mondal et 
al., 2013; Umar et al., 2015; Umar et al., 2016). Virus has been shown to be recovered 
from the blood and muscle of turkeys experimentally infected with HPAI H7N1 (Toffan 
et al., 2008). But with this particular virus, all birds were dead or clinically sick within 2 
days post infection, unlike what was seen with the current study. In addition, there is 
evidence indicating that the turkey’s immune response is not comparable the chickens’. 
The HPAI H5N2 virus involved in the 2015-2016 outbreak was shown to have reduced 
adaptation and transmissibility in the chicken when compared to the turkey (Bertran, et 
al., 2016). Based on this information, one can conclude that the chicken and the turkey 
responded differently to the exact same virus. This would not be the first time that the 
turkey was known to respond differently to the same pathogen and lead to increased 
pathogenesis (Powell et al., 2009). Furthermore, there is greater divergence at the 
proteome level between the chicken and turkey than there is between humans and 
chimpanzees (Arsenault et al., 2014), offering additional proof that the immune system 
of these two avian species are substantially different.     
 
There are no documented cases of HPAI in wild turkeys, despite the massive 
outbreaks in the domestic populations. When compared to their wild counterparts, the 
modern domestic turkey has shown to have decreased heterophil function (Genovese et 
al., 2006) as well as reduced or inefficient TLR signal transduction which are important 
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in detecting and protecting against viruses (Genovese et al., 2007). The potential 
influence the inferior immune response of the domestic turkey has on HPAI 
pathogenesis has yet to be elucidated. Viral pathogenesis and interactions with the host 
response with regards to HPAI in turkeys is mainly unidentified.  
 
Information regarding experimentally infected turkeys with HPAIs is novel and 
minimal and information detailing the response of naturally infected turkeys does not 
exist. Field data from naturally infected turkeys is essential for describing and 
understanding the dynamics of the disease during an outbreak. A better understanding of 
the host’s immune response, as well as the characteristics of the virus under field 
conditions may offer insight into better controlling strategies or options to controlling 
the disease without impacting international trade (USDA-APHIS, 2015).  
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CHAPTER II                                                                                                             
VIRAL DISTRIBUTION, SEMI-QUANTITATIVE VIRAL LOAD IN THE TISSUES, 
AND QUALITATIVE TISSUE ANALYSIS 
 
 
Overview  
The outbreak of the highly pathogenic avian influenza virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. The 
outbreak crippled both the turkey and egg laying industries. Up to that point, minimal 
research had been done regarding HPAIs in the turkey. This study examined viral 
distribution, semi-quantitative viral load, and histological viral lesions in 8 tissues from 
clinical, sub-clinical, and negative control birds: brain, heart, GI, liver, lung, 
reproductive tract, spleen, and trachea.  The matrix gene was detected in all 8 of the 
tissues in the clinical and sub-clinical groups. The clinically affected birds had 
significantly lower Ct values, or higher matrix gene content, in the brain, GI, spleen, and 
trachea than the sub-clinically affected turkeys. 
 
Interestingly, with the massive mortality associated with this outbreak, 
histological viral lesions were in general very mild and insignificant. The majority of the 
histological changes were confined to the trachea and liver in the clinically positive birds 
and primarily consisted of the infiltration of small numbers to heterophils, lymphocytes, 
and macrophages. In addition to the changes seen in the trachea and livers, the sub-
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clinical birds displayed more birds with infiltration of heterophils, lymphocytes, and 
macrophages in the oviduct and heart.  
 
Introduction 
Avian influenza (AI) viruses are part of the Orthomyxoviridae family and genus 
Influenzavirus (Suarez, 2008). The entire viral genome consists of eight single-stranded, 
negative sense, RNA segments (Perdue, 2008; Adam and Sandrock, 2010). The surface 
of the virion is covered with two types of glycoprotein projections; hemagglutinin (HA) 
and neuraminidase (NA) (Vasin et al., 2014). There are 16 HA antigenic strain 
classifications based on haemagglutination-inhibition (HI) and 9 NA antigenic strain 
classifications based on neuraminidase-inhibition (NI) (Stallknecht and Brown, 2008).  
 
All AI viruses are Type A influenza viruses and infect a large variety of hosts 
including birds, pigs, and humans. Domestic fowl are not considered to be natural hosts 
of the virus, but typically become readily infected. Waterfowl and shore birds of the 
orders Anseriformes and Charadriformes are natural, asymptomatic, infectious reservoirs 
(Swayne and Pantin-Jackwood, 2008; Cardona et al., 2009). An HPAI typically arises 
from infections of LPAI of the H5 and H7 serotypes circulating in domestic fowl (Zhao 
el al., 2012). The HA LPAI viruses can only be cleaved by trypsin-like proteases found 
in the respiratory and digestive tracts (Horimoto and Kawaoka, 2005 and Suarez, 2008). 
In contrast, the HA of HPAI viruses can be cleaved by ubiquitous proteases found in 
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most tissues, making systemic viral replication possible (Horimoto and Kawaoka, 2005 
and Post et al., 2012).  
 
While the HPAI virus and host interaction has been described to an extent in the 
chicken and duck (Blyth et al., 2016; Cardona et al., 2008; Kuchipudi et al., 2012; and 
Swayne, 2008), published literature regarding HPAIs and the turkey is scarce. Virus has 
been recovered from the blood and muscle of turkeys experimentally infected with HPAI 
H7N1 (Toffan et al., 2008) but virus characteristics and host susceptibility were very 
different than what would occur with a different virus and under natural field conditions. 
It is also unknown if what has been previously seen in the chicken is applicable to the 
turkey as there is greater divergence in the proteome level between the chicken and 
turkey than initially thought (Arsenault et al., 2014). The HPAI H5N2 virus involved in 
the 2014-2015 outbreak was shown to have reduced adaptation and transmissibility in 
the chicken when compared to the turkey (data pending pub.). Furthermore, nearly 70% 
of cases reported during the outbreak involved turkeys (USDA-APHIS, 2015).  Based on 
this information, one can conclude that the chicken and the turkey responded differently 
to the exact same virus. This would not be the first time that the turkey was known to 
respond differently to the same pathogen and lead to increased pathogenesis (Powell et 
al., 2009).   
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H5N2 Outbreak of 2014-2015 
The outbreak of the Highly Pathogenic Avian Influenza Virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. Within six 
months of its first detection, HPAI H5N2 destroyed nearly 50 million birds in 21 states, 
making it the largest animal disease outbreak in United States history (UDSA-APHIS, 
2015). It devastated the egg laying and turkey industries in the upper Midwest and cost 
the government over $950 million to stop the disease.  
 
This study examined the viral distribution and semi-quantification of the matrix 
gene in the brain, heart, GI, lung, liver, reproductive tract, spleen and trachea of turkey 
breeder hens. Tissues were further categorized by clinical or sub-clinical bird status. 
Histopathology was also conducted on all of the tissues. This is the first study of its kind 
that characterizes the 2014-2015 HPAI H5N2 virus in naturally infected turkey breeder 
hens with regards to viral distribution and semi-quantitative viral loads in addition to 
describing histological lesions. This information enhances the general understanding and 
properties of the virus and the histological changes in the turkey during the spring 2015 
outbreak of HPAI H5N2. In general, information regarding HPAIs in experimentally 
infected turkeys is minimal and information detailing the response of naturally infected 
turkeys does not exist. Field data from naturally infected turkeys is essential for 
describing and understanding the dynamics of the disease during an outbreak.  
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Materials and Methods 
Experimental Birds/Tissue Collection   
Breeder flocks used in the trial were both located on an AgForte (Willmar, MN) 
Independent Egg Producer’s (IEP) farm.  Each flock was comprised of Hybrid Converter 
turkey breeder hens approximately in the 28th week of egg production. The layout of the 
two sites was similar. Each farm had two laying hen barns that were connected by a 
central corridor with an egg washer and egg cooler. Farm management was similar 
between the farms. Birds were hatched and then brooded and grown together on their 
respective farms, prior to being divided into their respective lay barns. The positive flock 
used for the trial was located near Belgrade, MN. The site housed approximately 7,000 
breeder hens, which were divided between Barn-1 and Barn-2. The flock was sampled in 
April during the outbreak of HPAI H5N2 in Minnesota. The negative control flock of 
was located near Benson, MN. The Benson flock consisted of approximately 10,000 
birds turkey breeder hens, split between two barns, in their 28th week of production. The 
flock was sampled in October when the HPAI outbreak was over.  Every effort was 
made to find an appropriate negative control flock, however due to the spread of HPAI 
in breeder turkeys none were found during the outbreak time period.  
 
Collection of Tissues from Infected Birds during HPAI H5N2 Outbreak 
The positive flock was in an HPAI control zone and identified and chosen via 
active flock surveillance in accordance with the USDA’s HPAI Response Plan. On April 
23, 2015 tracheal swabs from Barn-1 were suspect for HPAI H5N2 based on qRT-PCR 
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with a Ct value of 36.27. On April 24, Barn-1 tested positive with a Ct value of 20.92. 
Cycle threshold values greater than 40 were considered negative, 35-40 were suspect, 
and values less than 35 were positive. 
 
On April 25, one day after the barn tested positive, ten clinically affected hens, 
nearing death, were randomly selected for the study. Tracheal swabs were taken and then 
pooled to five samples per tube in brain heart infusion (BHI) tubes. Birds were then 
humanly euthanized according to Ag Forte’s animal welfare guidelines via cervical 
dislocation with a Koechner® euthanasia device (Tipton, MO). An approximately one 
cm3 section of the heart, liver, spleen, trachea, lung, intestine (adjacent to the Meckel’s 
diverticulum), oviduct (magnum), and forebrain were collected and placed into a bottle 
containing 35 mL of 10% neutral buffered formalin (Fisher Scientific, Fremont, CA). 
Tissues from each bird were pooled in individual containers and labeled. An 
approximate 0.5 g piece of the adjacent tissue was taken from the previously mentioned 
tissues and placed in 0.5 mL of RNAlater® (Qiagen®, Valencia, CA). The trachea and 
intestinal tract were rinsed with sterile saline prior to being placed in the RNAlater®. 
Tissues were held for 24 hours at 4 °C and then stored at -80 °C.  
 
Due to the rapid spread of HPAI and a bottleneck on resources and depopulation 
crews, it took anywhere from days to weeks to depopulate infected premises. According 
to the HPAI Rapid Response Plan, the goal is to depopulate the flock within 24 hours of 
testing positive (USDA-APHIS 2015). Therefore 3 days later, 10 “non-clinical” birds 
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were randomly selected. The birds were euthanized and tissues were collected as 
previously described.  
 
Collection of Tissues from Negative Control Birds  
One of the pooled tracheal samples taken from the proposed control birds in 
Barn-2 at the Belgrade farm tested suspect on day of collection with a Ct value of 38.69. 
Therefore, 4 months after the last detected case of H5N2, a flock of comparable genetics, 
weeks in lay, and management style as the positive flock was identified to serve as the 
negative control baseline. Ten normal hens from one barn were randomly chosen for the 
study. To ensure that the birds were AI negative, tracheal swabs were taken and pooled 
in BHI at five samples per tube. Hens were euthanized and tissues were collected in the 
same manner as previously described.  
 
RNA Extraction 
  RNA extraction was completed at the University of Minnesota’s Mid-Central 
Research and Outreach Center in Willmar, MN. Four birds from each of the groups, a 
total of 12 birds per tissue, were selected for RNA extraction. The RNA was extracted 
from the tissues using an RNeasy® Mini Kit (Qiagen) and prefilled 2 mL tubes 
containing MagNA® Lyser Green Beads (Roche Life Science®, Indianapolis, IN).  Prior 
to starting, 600 µL of Buffer RLT and β-mercaptoethanol (β-ME) (Qiagen), mixed at a 
rate of 1 µL β-ME to 1 mL Buffer RLT, was added to each MagNA® Lyser tubes. 
Approximately 30 mg of tissue was placed in the MagNA® Lyser Green Bead tubes and 
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homogenized using a MagNA® Lyser instrument at 8000 x g for 90 seconds. MagNA® 
Lyser Green Bead tubes were then centrifuged at maximum speed for 3 minutes. Next, 
350 µL of the supernatant was pipetted into a new 2 mL microcentrifuge tube along with 
350 µL of 70% ethanol and thoroughly mixed via a pipette. The solution was transferred 
to an RNeasy® spin column and centrifuged at 8000 x g speed for 30 seconds. The flow-
through was discarded. Then, 700 µL of RW1 Buffer (Qiagen) was added to the column 
and the column was spun at 8000 x g for 30 seconds. The flow through was again 
discarded. Next, 500 µL of RPE Buffer (Qiagen) was added to the column and spun for 
30 seconds at 8000 x g. The flow-through was discarded and an additional 500 µL of 
RPE Buffer was added to the column and spun for 2 minutes. The column was then 
transferred into a new 2 mL collection tube and spun at maximum speed for 1 minute. 
The column was then transferred into a 1.5 mL collection tube and 50 µL of RNase free 
water (Qiagen) was added. The column was spun at 8000 x g for 1 minute and the RNA 
eluate was aliquoted into 4, 10 µL samples, and stored at -80 °C.  
 
Histological Preparation  
The tissues for histological examination were prepared and processed by the 
University of Missouri in Columbia, MO. After fixation, the tissues were dehydrated in 
varying concentrations of alcohol ranging from 30-90%. Tissues were then trimmed and 
embedded in Paraplast® (Leica Biosystems®, Buffalo Grove, IL) for cross sectioning. A 
5 µm transverse slice was sectioned, placed on a microscope slide, and stained with 
hematoxylin-eosin. All tissues from all birds collected were examined for histological 
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changes. Tissues were compared to the control group and significant histological 
changes reported. 
 
Viral Detection and Semi-Quantification in the Tissues 
Viral detection and semi-quantification was carried out by technicians at the 
University of Minnesota’s Mid-Central Research and Outreach Center. Previously 
extracted RNA, matching those samples that were in the cytokine analysis, was used for 
this process: 3 clinical, 3 non-clinical, and 2 negative controls. To ensure the quality and 
quantity of the RNA was preserved, it was reassessed using a NanoDrop® 
spectrophotometer. All RNA samples were standardized to 12 µL with RNase-free water 
to contain 500 ng/µL. The PCR tests were set up and carried out using an AgPath® One 
step RT-PCR kit (Life Technologies, Grand Island, NY). The RT-PCR master mix was 
prepared as follows for each reaction: 12.5 µL of 2× master mix, 1 µL of enzyme mix, 
1.6 µl detection enhancer, 0.5 µL of the M+25 forward primer, 0.5 µL of the M-124 
reverse primer, 0.5 µL of the M-124SIV reverse modified primer, 0.5 µl of M+64 Probe, 
and 0.5 µl of RNase inhibitor. Next, 8 µl of RNA was then added to each reaction. 
Negative and positive controls were used with the reaction. The procedure, probes, and 
primers used have been validated by the USDA for the detection of Type A influenzas 
(Spackman, 2014) (Table 1. Primers and Probes)  
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Matrix Gene 
Primer/Probes 
Sequence (5’-3’) 
M+25 Forward Primer AGA TGA GTC TTC TAA CCG AGG TCG 
M+64 Probe 56-FAM/TC AGG CCC CCT CAA AGC CGA /36-TAMSp 
M-124 Reverse Primer TGC AAA AAC ATC TTC AAG TCT CTG 
M-124SIV (Reverse 
Modified Primer) 
TGC AAA GAC ACT TTC CAG TCT CTG 
Table 1. Probe and primer sequences used for the matrix gene. 
The PCR analysis was then run on an Applied Biosystems® 7500 Real-Time 
PCR System. See Table 2 for cycling conditions. Melting curves and amplification plots 
were analyzed for specificity. 
Step Stage Reps Temp Time 
Reverse 
Transcription 
1 1 45ºC 10 min 
RT 
Denaturation 
2 1 95ºC 10 min 
Amplification 3 45 94ºC 
60ºC 
15 sec 
45 sec 
Table 2. PCR cycling conditions used in the matrix gene analysis. 
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Statistical Analysis 
Results were expressed as Ct values. A Student’s T-test was conducted on all Ct 
values using JMP® Pro 12 software. Probability (p)-values <0.05 were considered 
statistically significant. 
 
Results and Discussion  
Tissue Collection 
Based on active surveillance, it is presumed that the flock was exposed on April 
23, 2015, when viral RNA was first detected at a very low level in the barn. On April 24, 
2015, the day the flock officially tested positive, mortality and clinical signs in Barn-1 
were minimal; less than a dozen turkeys died and activity was only slightly depressed 
from normal. On April 25, one day after the barn tested positive, mortality was roughly 
40% by mid-morning and increasing rapidly and the barn was unusually quiet with 
minimal bird activity (Figure 3). Birds were weak and feverish to the touch. Some birds 
stood in a hunched position with their heads hanging down while others sat on their 
hocks in a comatose state with their pupils fully dilated and irises a very pale gray color 
as opposed to the normal blue (Figures 4, 5, and 6). Ruffled feathers, paralysis and 
incoordination have been reported previously in chickens infected with HPAI (Spickler 
et al., 2008) but other respiratory symptoms sometimes associated with infected chickens 
was not seen.  
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Figure 1. Flock behavior. 
 
 
Figure 2. Typical bird stance. 
 
   
Figure 3. Image of the eye with dialated pupil. 
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Figure 4. Image of the eye. 
 
Cloudy and fibrinous pericardial sacs, hemorrhaging on the spleen, and 
regression of the oviducts of varying degrees were noted upon necropsy in a few of the 
birds (Figures 7 and 8). Besides the regression of the oviduct, the majority of the birds 
did not have any observable lesions upon necropsy. Three days after the barn tested 
positive, on April 27, mortality was approximately 90%. Approximately 5% of the flock 
survived and appeared to be “unaffected” or “non-clinical” (Figures 9 and 10). They 
were active, alert, and not feverish. Necropsy lesions were minimal and similar to those 
seen with the clinical birds.  
 
 
Figure 5. Example of heart lesions. 
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          Figure 6. Example of spleen lesions. 
 
 
 
Figure 7. Non-clinical bird. 
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Figure 8. Another non-clinical bird example. 
 
 
 
Virus Distribution 
 Virus was found in all of the eight tissues collected from the clinical and non-
clinical birds: brain, GI, heart, liver, lung, reproductive tract, spleen, and trachea. The 
matrix gene was not detected in any of the negative control tissues. The clinical birds 
had significantly lower Ct values in the brain, GI, spleen, and trachea than the non-
clinical indicating the increased presence of virus in those tissues. See Figure 11 and 
Table 3.  
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Figure 9. Mean Ct values with standard error bars for positive tissues by clinical 
and sub-clinical status. Statistical analysis of tissues comparing clinical and sub-
clinical status. Tissues with the same symbol indicate that Ct values for that 
particular tissue are statistically different from each other. N=48.P-values <0.05 
were considered significant.  
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Tissue 
Clinical 
Mean Ct 
Standard 
Error 
Sub-Clinical 
Mean Ct 
Standard 
Error 
Brain 16.23 0.24 23.00 1.93 
GI 18.56 0.86 21.80 0.68 
Heart 15.4 1.08 17.75 1.40 
Liver 23.11 1.29 24.97 1.28 
Lung 17.30 1.30 18.50 0.65 
Repro 15.21 0.63 15.78 1.49 
Spleen 17.24 0.75 24.07 1.41 
Trachea 16.55 0.27 19.93 0.54 
 
Table 3. Mean Ct values with standard error for positive tissues by clinical and 
sub-clinical status. 
 
 When considering all of the tissues from all birds, the sub-clinical birds had 
significantly higher Ct values compared to the clinical birds, 20.73 with a standard error 
of 0.74 and 17.45 with a standard error of 0.56 respectively, indicating less virus present 
in the tissues overall of the non-clinical birds. (Figure 12).  Of all positive tissues, the 
reproductive tracts, heart, lung, and trachea tended to have the lowest Ct values. The 
reproductive tract had significantly lower Ct values than all other tissues on the contrary 
the liver had significantly higher Ct values than all other tissues (Figure 13). Among the 
clinical birds, the reproductive tract and the heart had the most virus while the liver and 
the GI had the least. The hearts and reproductive tracts contained the most virus in the 
non-clinical birds while the liver and spleen had the least. (Figures 14 and 15). 
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Figure 10. Mean Ct of all tissues combined by clinical and non-clinical status. N=48. 
P-values <0.05 are statistically significant. 
 
 
 
 
Figure 11. Mean Ct and analysis of tissues of all positive birds regardless of clinical 
status. N=48. P-values <0.05 are statistically significant. 
 
Tissue Mean 
Ct 
Standard 
Error 
Liver 24.04 0.91 
Spleen 20.66 1.68 
GI 20.18 0.88 
Brain 19.61 1.75 
Trachea 18.24 0.80 
Lung 17.90 0.70 
Heart 16.58 0.95 
Repro 15.50 0.74 
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Figure 12. Mean Ct and analysis of tissues among clinical birds by. N=24. P-values 
<0.05 are statistically significant. 
 
 
Figure 13. Mean Ct and analysis of tissues among non-clinical birds. N=24. P-
values <0.05 are statistically significant. 
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Based on the detection of the matrix gene using rRT-PCR, virus was detected in 
the tissues of all birds collected from the HPAI affected barn, regardless if the bird was 
clinical or sub-clinical. The virus was found in multiple tissues throughout the body, 
which is consistent with what has been previously reported with HPAI infections in 
other species of birds including the chicken and the pigeon. The virus has been reported 
in the blood and muscle of turkeys infected with HPAIs (Toffan et al., 2008), but its 
presence in the other tissues was not previously described. Not only does this current 
study show that the virus can be found in the brain, heart, GI, liver, lung, reproductive 
tract, spleen, and trachea, but it is found in significantly different amounts in the tissues. 
The reproductive tract, heart, and lung had the lowest Ct values among the positive birds 
indicating that the virus was able to replicate more rapidly in those tissues. This is 
consistent with the lesions that were observed upon necropsy. 
 
There is also a significant difference in the amount of virus found in the tissue of 
clinical versus sub-clinical birds. The clinical birds had the lowest Cts and highest 
Matrix gene detection in the reproductive tract, followed by the heart, brain, trachea, 
spleen, lung, GI, and liver. The sub-clinical birds had a somewhat different Ct profile. 
The sub-clinical birds also had the lowest Cts and highest Matrix gene detection in the 
reproductive tract, followed by the heart but the differed thereafter. The heart was 
followed by the lung, trachea, GI, brain, spleen, and liver. The sub-clinical birds had 
significantly higher Ct values in the brain, GI, spleen, and trachea than the clinical birds. 
The largest Ct differences between groups was with the spleen and the brain, 6.83 and 
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6.77 respectively. The lower Ct values in the clinical birds, particularly in the brain, is 
likely responsible for the comatose like behavior, pale irises, and dilated pupils seen 
prior to tissue collection. The ability of HPAI to replicate in the brain was shown to set it 
apart from the LPAI (Post et al., 2012). The higher levels of virus in the brain may 
explain the clinical signs. The differences seen in matrix gene levels and subsequent Ct 
values provide further insight into differences between clinical and sub-clinical birds.  
 
Histology  
Historically, there is variability with regards to site and extent of the lesions 
between strains of HPAI (Mo et al., 1997). The most common histological lesions 
associated with HPAIs are multi-organ necrosis and inflammation of the brain, heart, 
pancreas, and lymphoid organs (Saif, 2003) as well as swelling of the microvascular 
endothelium, systemic congestion, perivascular mononuclear cell infiltration, multifocal 
hemorrhages, and thrombosis (Kobayashi et al., 2007). None of this was seen with the 
current trial. 
 
There were a variety of lesions seen in the clinically positive birds, the most 
predominant being in the trachea and liver. In general, the histological lesions were mild. 
In 6/10 birds, the mucosal lining of the trachea was infiltrated by small numbers of 
lymphocytes and macrophages (Figure 16). In addition, many epithelial cells in the 
mucosal lining were vacuolated in one bird. See Figure 17. Out of the clinical birds 
examined, 8/10 had various parts of the liver infiltrated by small numbers of heterophils, 
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lymphocytes and macrophages. Two of the birds had lesions in the oviduct: one bird had 
a few clumps of heterophils, macrophages, and fibrin adhered to the serosa of the 
oviduct, the oviduct of the other bird contained proteinaceous fluid and degenerated 
heterophils in the lumen. One bird had a few lymphoid nodules in the lamina propria of 
the intestine and another had multiple foci in the spleen in which the sinusoids contained 
fibrin (Figure 18).  
 
The sub-clinical birds had a few similar lesions but a few very different ones as 
well. Similarly, they had trachea and liver lesions; 6/10 birds had small numbers of 
lymphocytes and macrophages infiltrating the mucosal lining of the trachea. 5/10 birds 
had infiltration of a small to moderate number of macrophages, lymphocytes, and 
heterophils in the various sections of the liver (Figure 19). The sub-clinical birds had 
lesions in the oviduct as well: 4/10 had small numbers of heterophils, lymphocytes, and 
macrophages infiltrating the lamina propria or serosal lining of the oviduct (Figure 20). 
Unlike the clinical birds, birds from the non-clinical group had heart and brain lesions. 
There were 3/10 birds with heart lesions: one of them had a moderate number of 
macrophages, lymphocytes, and heterophils infiltrating the epicardium, and two birds 
had a thick layer of fibrin and degenerated inflammatory cells covering the epicardium 
(Figure 21). Only one bird exhibited lesions of the brain. The medium-sized blood 
vessels of the brain were cuffed by small numbers lymphocytes and there were a few 
foci of necrosis in the white matter that were infiltrated by small numbers of 
macrophages and lymphocytes. See Figure 22. The additional lesions seen in the sub-
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clinical birds may be from a different or more protective immune response or simply 
from being sacrificed/infected 2 days longer than the clinical birds.  
 
The lack of significant histological lesions, despite viral presence, is not 
surprising, as similar results have been seen with certain HPAIs previously in chickens.  
The majority of the histological changes were confined to the trachea and liver in the 
clinically affected birds and primarily consisted of the infiltration of small numbers of 
heterophils, lymphocytes, and macrophages. The sub-clinical birds also saw in increase 
in infiltration of the heterophils, lymphocytes, and macrophages in the oviduct and heart. 
The increased infiltration of immune cells in the tissues of the sub-clinically affected, 
may potentially indicate a more protective host response. The presence of the virus in the 
brain, not only in the current study but also in previous studies, has led to the question as 
to how the virus penetrates the blood/brain barrier. It has been speculated that is comes 
directly through the bloodstream. The cuffing of the medium sized blood vessels with 
lymphocytes supports that hypothesis.  
 
Lesions are often times a result of viral replication and consequent tissue damage 
to the visceral organs (Saif, 2003). This was not the case in the current study, as virus 
was detected in the absence of tissue damage. The virus has been shown to inhibit 
cellular apoptosis of various cells (Ekchariyawat et al., 2011) and the lack of apoptosis 
in the tissues, despite presence of the virus, indicates this may have been occurring. The 
lack of histological lesions is interesting but not surprising given the very rapid onset of 
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mortality. The increased infiltration of immune cells in the tissues of the sub-clinically 
affected birds may indicate a superior or more efficient immune response. Based on the 
histological analysis, it is very obvious that organ necrosis was not killing the birds. The 
results then indicate that another factor, other than multi-organ necrosis, such as 
hypercytokinemia or cytokine storm may be responsible for the deadly outcome. 
Immunohistochemistry on all tissues is currently being pursued. Being able to pinpoint 
and describe the exact location of the virus in the tissues will provide further insight into 
its cellular distribution and replication.       
 
              
Figure 14. Mucosal lining of the trachea of an affected bird infiltrated by small 
numbers of lymphocytes and macrophages (left) and the trachea of a control bird 
(right). 
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Figure 15. Vacuolated epithelial cells in the trachea of an affected bird (left) and the 
trachea of a negative control. 
 
 
        
Figure 16. Lymphiod depletion in the spleen and multiple foci with the sinusoids 
containing fibrin (left) and control (right). 
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Figure 17. Acute necrosis of the liver, infiltrated by small numbers of heterophils, 
lymphocytes, and macrophages in the hepatic parenchyma (left). Portal tracts of 
the liver containing heterophils, lymphocytes, and macrophages (right). 
 
 
 
Figure 18. The oviduct inflitrated by small numbers of heterophils, lymphocytes, 
and macrophages. 
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Figure 19. Fibrin and degenerated inflammatory cells covering the epicardium and 
a moderate number of macrophages, lymphocytes, and heterophils infiltrating the 
epicardium. 
 
 
            
Figure 20. The medium-sized blood vessels of the brain cuffed by small numbers 
lymphocytes (left) and the brain of a control bird (right). 
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Conclusion 
Despite the massive devastation it caused, very little is known about the specific 
virus, particularly regarding its distribution and lesions caused within the turkey host 
during the outbreak. It was unknown as to why there was a very small population of 
turkeys that would survive the massive mortality and appear unaffected several days 
later. We now know that all of the birds were indeed infected but the viral load and 
presence was very different in the clinically affected versus sub-clinically affected. The 
viral load was higher in the brain, GI, spleen, and trachea of the clinically affected birds. 
The increased viral concentration in the brain most likely contributed to the neurological 
symptoms observed in the clinically affected turkeys.  
 
Histological changes and lesions were generally mild and insignificant. Changes 
were predominantly seen in the liver and the trachea and primarily consisted of the 
infiltration of small numbers of heterophils, lymphocytes, and macrophages. The liver 
had the lowest concentration of virus yet some of the most changes. The mechanisms 
and subsequent reasoning behind these observations need to be further explained. Based 
on the lack of pathological and histological lesions, some mechanism other than multi-
organ necrosis was responsible for the fatal outcome.    
 
This study is the first of its kind that provides virus distribution and semi-
quantitate matrix gene analysis across multiple tissues in the turkey. It is also the first of 
its kind that characterizes the differences in distribution and matrix gene levels between 
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clinical and sub-clinical birds. The virus appeared to replicate more rapidly in the 
clinically affected birds, particularly in the brain and reproductive tracts. Understanding 
why the difference was seen is important in understanding the virus-host interaction. 
Due to the propensity and virulence of the virus and barn design, it can be assumed that 
all birds were exposed to the virus within a very short time frame. The reasons as to why 
a small portion of the birds survived the massive mortality on day 2 and were sub-
clinical 4 days after the matrix gene was first detected in the barn has yet to be 
explained. Although the virus was found in all of the tissues, the exact location in the 
tissues needs to be elucidated.   
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CHAPTER III                                                                                                             
GENE EXPRESSION 
 
Overview 
The outbreak of the highly pathogenic avian influenza virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. The turkey 
industry was the most affected with nearly 70% of the confirmed cases were in turkeys. 
Minimal research has been done on the effects of HPAI infection on turkeys, particularly 
on the subject of host response. This study examined changes in the gene expression of 
several components across 8 different tissues: brain, heart, GI, liver, lung, reproductive 
tract, spleen and trachea. The pro-inflammatory cytokines IL-1β and IL-6, the anti-
inflammatory cytokine IL-10, and chemokines CCL-5 and CXCLi-2 were studied as 
well as the antiviral components Mx, OASL, and IFN-γ, IFIH1 the gene that encodes for 
the MDA5 signaling mechanism, and the death ligands FasL and TRAIL The results are 
indicative that the virus was very efficient at evading early detection and inhibiting anti-
viral defenses.  
 
There was no indication of an excessive pro-inflammatory response or 
pathogenesis induced by a cytokine storm. This particular virus was able to avoid initial 
detection by suppressing the expression of viral detecting mechanisms, pro-
inflammatory cytokines, and antiviral components in the trachea. Undetected, the virus 
quickly disseminated throughout the body and replicated very rapidly.  A widespread  
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downregulation of IFN-γ and upregulation mRNA expression of CCL-5 and OASL 
appeared to contribute to the pathogenesis. Death was a result of viral load in the tissues 
and subsequent organ failure. 
 
Introduction 
Avian influenza (AI) viruses are part of the Orthomyxoviridae family and genus 
Influenzavirus (Suarez, 2008). The entire viral genome consists of eight single-stranded, 
negative sense, RNA segments (Perdue, 2008; Adam and Sandrock, 2010). The surface 
is covered with two types of glycoprotein projections; hemagglutinin (HA) and 
neuraminidase (NA) (Vasin et al., 2014). While the HPAI virus and host interaction has 
been described to an extent in the chicken and duck (Blyth et al., 2016; Cardona et al., 
2008; Kuchipudi et al., 2012; Swayne, 2008), published literature regarding HPAI 
infections in turkeys is scarce. It is also unlikely that what has been previously seen in 
with regards to immune response in the chicken is applicable to the turkey, as immune-
mechanisms between the species is different (Arsenault et al., 2014). The HPAI H5N2 
virus involved in the 2014-2015 outbreak was shown to have reduced adaptation and 
transmissibility in the chicken when compared to the turkey (data pending pub.). Nearly 
70% of cases reported during the outbreak involved turkeys (USDA-APHIS, 2015).  
This would not be the first time that the turkey was known to respond differently to the 
same pathogen and lead to increased pathogenesis (Powell et al., 2009).   
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Even with a highly evolved and complex immune system in the host, AI viruses 
are still able to evade it. Virulence can be correlated with immune evasion (Perdue, 
2008; Swayne and Suarez, 2000). Avian influenza viruses use several tactics to elude the 
immune system. The virus is known for its high mutability and reassortment capabilities 
(Perdue, 2008; Swayne and Suarez, 2000). Mutating or reassorting changes the 
specificity of the antibody needed for host protection, thus resulting in increased viral 
replication and transmission of mutated strains (Hale et al., 2010. The non-structural 
(NS) viral proteins are critical in immune evasion. The NS1 protein can limit the 
production and effectiveness of the interferons, which inhibit viral replication, (Hale et 
al., 2010) by blocking the cytoplasmic RIG-I/MDA5 signaling cascade or by attenuating 
INF-inducible signaling (Hale et al., 2010 and Vijayakumar et al., 2015). The protein 
can suppress the Fas/Fas-ligand-mediated apoptosis thus increasing the infectivity (Xing 
et al., 2009). The virus can induce and/or inhibit cellular apoptosis of various cell types 
including immune cells (Ekchariyawat et al., 2011), increase viral replication speed 
(Hale et al., 2010) and induce cytokine deregulation of the host (Kuribayashi et al., 
2013).  
 
H5N2 Outbreak of 2014-2015 
The outbreak of the Highly Pathogenic Avian Influenza Virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. Within six 
months of its first detection, HPAI H5N2 destroyed nearly 50 million birds in 21 states, 
making it the largest animal disease outbreak in United States history (UDSA-APHIS, 
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2015). It devastated the egg laying and turkey industries in the upper Midwest and cost 
the government over $950 million to stop the disease. 
The present study provides insight to understanding the host response in naturally 
infected turkeys. This study examined changes in the transcription of several host 
defense genes across 8 different tissues: brain, heart, GI, liver, lung, reproductive tract, 
spleen and trachea. The pro-inflammatory cytokines IL-1β and IL-6, the anti-
inflammatory cytokine IL-10, and chemokines CCL-5 and CXCLi-2 were studied as 
well as the antiviral components Mx, OASL, and IFN-γ, IFIH1 the gene that encodes for 
the MDA5 signaling mechanism, and the death ligands FasL and TRAIL. This is the first 
study of its kind that characterizes the 2014-2015 HPAI H5N2 virus in naturally infected 
turkey breeder hens with regards to the host response. This information enhances the 
general understanding and properties of the virus and host interaction during the turkey 
during the spring 2015 outbreak of HPAI H5N2. 
Materials and Methods 
RNA Extraction 
RNA extraction was completed at the University of Minnesota’s Mid-Central 
Research and Outreach Center in Willmar, MN. Four birds from each of the groups, a 
total of 12 birds per tissue, were selected for RNA extraction. The RNA was extracted 
from the tissues using an RNeasy® Mini Kit (Qiagen) and prefilled 2 mL tubes 
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containing MagNA® Lyser Green Beads (Roche Life Science®, Indianapolis, IN).  Prior 
to starting, 600 µL of Buffer RLT and β-mercaptoethanol (β-ME) (Qiagen), mixed at a 
rate of 1 µL β-ME to 1 mL Buffer RLT, was added to each MagNA® Lyser tubes. 
Approximately 30 mg of tissue was placed in the MagNA® Lyser Green Bead tubes and 
homogenized using a MagNA® Lyser instrument at 8000 x g for 90 seconds. MagNA® 
Lyser Green Bead tubes were then centrifuged at 8000 × g. Next, 350 µL of the 
supernatant was pipetted into a new 2 mL microcentrifuge tube along with 350 µL of 
70% ethanol and thoroughly mixed via a pipette. The solution was transferred to an 
RNeasy® spin column and centrifuged at 8000 × g speed for 30 seconds. The flow-
through was discarded. Then, 700 µL of RW1 Buffer (Qiagen) was added to the column 
and the column was spun at 8000 × g for 30 seconds. The flow through was again 
discarded. Next, 500 µL of RPE Buffer (Qiagen) was added to the column and spun for 
30 seconds at 8000 × g. The flow-through was discarded and an additional 500 µL of 
RPE Buffer was added to the column and spun for 2 minutes. The column was then 
transferred into a new 2 mL collection tube and spun at maximum speed for 1 minute. 
The column was then transferred into a 1.5 mL collection tube and 50 µL of RNase free 
water (Qiagen) was added. The column was spun at 8000 × x g for 1 minute and the 
RNA elute was aliquoted into 4, 10 µL samples, and stored at -80 °C.  
 
Reverse Transcription  
Reverse transcription and subsequent gene analysis took place in Dr. Zheng 
Xing’s lab at the University of Minnesota-St. Paul campus. The quality and quantity of 
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the RNA was assessed using a NanoDrop® spectrophotometer. The RNA was reverse 
transcribed to complementary deoxyribonucleic acid (c-DNA) using a QuantiTect® 
Reverse Transcription Kit (Qiagen). Genomic DNA elimination reactions were carried 
out using 2 µL of gDNA Wipeout Buffer 7× and a combination of template RNA and 
RNase-free water of various quantities to equal 500 ng/µL for a total of 12 µL. Solution 
was then incubated at 42 ºC for two minutes and held on ice. Reverse transcription 
reactions were carried out by mixing the previously incubated solution with 6 µL of 
reverse-transcription master mix. Master mix was comprised of 1 µL of Quantiscript® 
Reverse Transcriptase, 4 µL of Quantiscript® RT Buffer 5×, and 1 µL of RT Primer Mix 
per each reaction. Solutions were then incubated for 15 minutes at 42 ºC to initiate 
reverse transcription and then 3 minutes at 95 ºC to inactivate the Quantiscript® Reverse 
Transcriptase.   
 
Real-Time qPCR 
A total of 8 birds were run per tissue, 3 clinical, 3 non-clinical, and 2 negative 
controls. Each of the eight tissues were run on separate 96 well plates. The endogenous 
housekeeping gene, GAPDH was used as a standard control for changes in gene 
expression. Cytokines IL-1β, IL-6, CXCLi-2, IL-10, CCL-5, IFN-γ, Mx, OASL, IFIH1, 
FasL and TRAIL were ultimately examined. Based on previously published data and 
with the help of Primer 3 software, Dr. Xing designed and acquired the primers. See 
Table 1 below for primer sequences. Primers were diluted with RNase-free water to 10 
µM. Each PCR reaction was set up as follows: 0.5 µL of specific cytokine 5’ primer, 0.5 
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µL of the specific cytokine 3’ primer, 0.7 µL of reverse transcribed mRNA, 4.75 µL of 
dH2O, and 6.25 µL of 2× SYBR® Green PCR Master Mix (Applied Biosystems®, 
Carlsbad, CA).  
 
Gene Forward 5’ Primer Reverse 3’ Primer 
GAPDH gacgtgcagcaggaacacta cttggactttgccagagagg 
 
IL-1β ctctacatgtcgtgcgtgct 
 
ctgtccaggcggtagaagac 
 
IL-6 gacgaggagaaatgcctgag 
 
agcgattcgacattctgctt 
 
CXCLi-2 ccactgcaagaacgttgaaa 
 
ggccataagtgcctttacga 
 
IL-10 aagcgctgtcaccacttctt tcccgttctcatccatcttc 
 
CCL-5 cgcctacatcactagcagca 
 
agttccaggtggttctgcac 
 
IFN-γ agccgcacatcaaacacata 
 
catctgaagctttgccaggt 
Mx atgtgctgcaacaagcaaag 
 
tcctgcaaggaaaagcatct 
 
OASL caccacaagctggagcacta 
 
atagctcaggagggcacaaa 
 
IFIH1 aaaggcccaagaaaggaaaa 
 
ttccatgaatgcacaccact 
 
FasL gtggtgctgttgaaatgtgg  ggttttggcaacacaggact 
TRAIL gaggactcggatttgttgga atgagcagaatgggatctgg 
 
 
Table 4. Primer sequences 
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The plates were then run on an Applied Biosystems® 7500 Real-Time PCR 
System with standard cycling conditions. See Table 4 for cycling conditions. Melting 
curves and amplification plots were analyzed for specificity. Results were expressed as 
Ct values and standardized to the changes seen with GAPDH and the two separate 
internal controls. Fold changes were calculated using the universally accepted 2-ΔΔCt for 
each of the tissues and cytokines. Statistical analysis of the fold and gene expression 
changes of the ΔCt was carried out using a Student’s T-test using the JMP® Pro 12 
software for Windows (Microsoft, USA). Probability (p)-values <0.05 were considered 
statistically significant.  
 
Stage Reps Temp Time  
1 1 50ºC 1 min 
2 1 95ºC 5 min 
3 40 95ºC 
58ºC 
15 sec 
32 sec 
4 1 95ºC 
60ºC 
95ºC 
15 sec 
1 min 
15 sec 
 
Table 5. PCR cycling conditions used in gene expression analysis. 
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Gene Expression  
 The primer sequences designed for IFN-α and IFN-β did not work, therefore 
IFN-γ was used. It is not known if the sequence wasn’t designed correctly or if there 
were other reasons unique to the turkey, as the turkey genome is poorly annotated. While 
IFN-α and IFN-β have been studied in the chicken, IFN-γ is the only IFN documented in 
the turkey thus far (Gadde et al., 2011, Mondal et al., 2013 and Umar et al., 2016). Gene 
expression was analyzed using two different group configurations. In the first 
configuration, all the positive birds were grouped together, regardless of clinical status, 
and compared to the negative controls. In the second configuration, the positives were 
sub-divided into clinical and sub-clinical groups and compared against each other as 
well as the negative control birds.  Some tissues and cytokines were more difficult to 
obtain results from than others. The brain and reproductive tract were the most difficult 
tissues. In the previous study, these tissues had also had the highest concentration of 
viral load. It is unknown it contributed to the problems. Of the genes, IL-10 was the most 
problematic. Issues with IL-10 may possibly be tissue related. Similar to the current 
study, we previously were able to successfully study IL-10 across multiple areas of the 
GI tract without problem. When IL-10 was initially characterized in the turkey, 
expression in the GI was found to be consistent however expression in non-lymphoid 
tissues was found to be highly variable (Powell et al., 2012). Variation in cytokine 
response among individuals in a given population was seen with the current study but 
has been previously reported (Adams, 2009). Despite the obstacles, significant changes 
were seen with multiple cytokines in a number of tissues throughout the body.  
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Brain 
 It is uncertain as to why, but the brain was by far the most difficult of the eight 
tissues collected to obtain gene expression results. Gene expression in the turkey brain 
has not yet been studied. As a result of the gene expression challenges, some of the data 
are incomplete. Obtaining changes in the expression of IL-10, FasL, and IFIH1 for any 
of the groups and IL-1β, IL-6, and CXCLi-2 for the sub-clinical group was unsuccessful. 
Regardless of the gaps in the data, meaningful data were acquired. The changes seen 
with regards to anti-inflammatory cytokine expression in the brain were minimal 
compared to the anti-viral gene expression. Changes in IL-1β were negligible in the 
brains of the clinically affected birds, but IL-6 was significantly upregulated, 18.81 fold. 
Anti-inflammatory data were not obtained in the brain. The chemokine CCL-5 was 
significantly upregulated in the brains of clinically, 16.65 fold, and sub-clinically 
affected birds, 10.06 fold as well as in the positive group, 13.36 fold. Expression in the 
clinical and sub-clinical birds were statistically different from the negative controls as 
well as from each other. The antiviral gene Mx was significantly upregulated in the 
positive group, 3.15 fold, compared to the negative group. The clinically affected birds 
had significant upregulation of OASL, 256.58 fold, in the brain. IFN-γ was significantly 
down regulated, -1.52 fold, in the clinically affected, when compared to the sub-clinical 
and negative controls. The sub-clinical birds had a slight upregulation, 1.48 fold, of IFN-
γ. See figures 1-3.    
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Figure 21. Gene expression in the brain of positive birds. “*” denotes significant 
difference from controls. P-values <0.05 were considered to be significant.  
 
 
 
* * 
* 
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Figure 22. Cytokine and chemokine gene expression in the brain vs. clinical status. 
“*” denotes significant difference from controls. P-values <0.05 were considered to 
be significant.  
 
 
 
* 
* 
* 
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Figure 23. Antiviral, signaling, and apoptotic gene expression in the brain vs. 
clinical status. “*” denotes significant difference from controls. “a/b” denotes 
significant difference between clinical and sub-clinical groups. P-values <0.05 were 
considered to be significant.  
 
 
GI 
 Several differences were noted in gene expression in the GI. CCl-5 and OASL 
were significantly upregulated in the positive group, 4.58 and 25.77 fold respectively. 
Whereas, IFN-γ was significantly downregulated nearly 2 fold in the positive group. 
Changes in neither of the pro-inflammatory cytokines or anti-inflammatory cytokine 
were significant in the GI. Both chemokines, CCL-5 and CXCLi-2 were upregulated. In 
the clinically affected cases, CCL-5 was significantly upregulated from the controls, 
*a 
*b 
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4.88 fold. As was Mx and OASL, 14.51 and 30.0 fold respectively. IFN-γ was 
significantly down regulated -1.25 fold. See figures 4-6.   
 
 
Figure 24. Gene expression in the GI of positive birds. “*” denotes significant 
difference from controls. P-values <0.05 were considered to be significant.  
 
 
 
* 
* 
* 
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Figure 25. Cytokine and chemokine gene expression in the GI vs. clinical status. “*” 
denotes significant difference from controls. P-values <0.05 were considered to be 
significant.  
 
 
* 
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Figure 26. Antiviral, signaling, and apoptotic gene expression in the GI vs. clinical 
status. “*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant.  
 
 
Heart 
 No IL-10 data were obtained for the heart. Both pro-inflammatory cytokines 
were significantly upregulated in the positive birds. IL-1β was upregulated 3.23 fold and 
IL-6 was upregulated 12.81 fold. IFIH1 was also significantly upregulated in that group 
by 8.49 fold. Clinically affected birds had a significant upregulation of IL-1β, 8.84 fold, 
CCL-5, 81.76 fold, OASL, 459.93 fold, and IFIH1, 8.84 fold. The sub-clinical birds had 
an upregulation of IL-6, 12.43 fold. They were also considered statistically different than 
* 
*a 
* 
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the clinical birds regarding CCL-5 at 20.84 fold and OASL at 91.64 fold. See figures 7-
9. 
 
 
Figure 27. Gene expression in the heart of positive birds. “*” denotes significant 
difference from controls. P-values <0.05 were considered to be significant.  
 
 
* * * 
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Figure 28. Cytokine and chemokine gene expression in the heart vs. clinical status. 
“*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
 
 
*a 
b 
* * 
 74 
 
 
Figure 29. Antiviral, signaling, and apoptotic gene expression in the heart vs. 
clinical status. “*” denotes significant difference from controls. “a/b” denotes 
significant difference between clinical and sub-clinical groups. P-values <0.05 were 
considered to be significant.  
 
 
Liver  
 The positive birds had significantly higher expression of IFIH1, 1.42 fold, and 
OASL, 66.21 fold, and a downregulation of IFN-γ, -1.63 fold, in the liver. The clinically 
affected birds had higher IL-6, CCL-5, OASL, and IFIH1 expression, 2.1, 11.54, 72.19, 
and 1.54 fold respectively. They also had a down regulation in IFN-γ, -1.89 fold. FasL 
and OASL were up regulated in the sub-clinical birds, 64.23 and 60.23 fold. Meanwhile. 
IFN-γ and IL-6 were downregulated. See figures 10-12.   
 
* 
*a 
b 
 75 
 
 
 
Figure 30. Gene expression in the liver of positive birds. “*” denotes significant 
difference from controls. P-values <0.05 were considered to be significant.  
 
 
 
 
* 
* 
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Figure 31. Cytokine and chemokine gene expression in the liver vs. clinical status. 
“*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
 
* 
a b 
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Figure 32. Antiviral, signaling, and apoptotic gene expression in the liver vs. clinical 
status. “*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
 
 
Lung 
 The only significant changes in the lungs of the positive group of birds were with 
regards to IFN-γ. Its expression was significantly downregulated, 5.86 fold. Several 
significant differences were seen when looking at the clinical and sub-clinical groups. 
IL-1β was significantly different between the two groups, 2.17 fold in the clinical and 
6.95 fold in the sub-clinical. The sub-clinical group was considered different than the  
* 
 
*a *b 
* * * 
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negative controls. In addition, both CCL5 and CXCLi-2 were expressed at a much 
higher rate than the controls, 13.74 fold and 6.66 fold respectively. The antiviral IFN-γ 
gene was downregulated, -9.89 fold, in the clinically affected and considered to be 
different than the controls as well as the sub-clinical group whose mean fold change was 
-3.16. OASL was significantly upregulated in the sub-clinical but not the clinical. See 
figures 13-15.   
 
 
Figure 33. Gene expression in the lung of positive birds. “*” denotes significant 
difference from controls. P-values <0.05 were considered to be significant.  
 
 
 
* 
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Figure 34. Cytokine and chemokine gene expression in the lung vs. clinical status. 
“*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
 
 
 
a 
*b 
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Figure 35. Antiviral, signaling, and apoptotic gene expression in the lung vs. clinical 
status. “*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
 
 
Reproductive Tract 
 No IL-10 data was acquired for the reproductive tract. Although cytokine trends 
were seen with regard to the oviduct, cytokine variability and control bird issues resulted 
in statistically insignificant results. IL-1β, IL-6, CCL5, CXCLi-2, MX, OASL, and FAS 
tended to be upregulated while IFN-γ and TRAIL tended to be downregulated. See 
figures 16-18. 
*a b 
* 
 81 
 
 
Figure 36. Gene expression in the oviduct of positive birds. 
 
 
Figure 37. Cytokine and chemokine gene expression in the oviduct vs. clinical 
status. 
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Figure 38. Antiviral, signaling, and apoptoic expression in the oviduct vs. clinical 
status. 
 
 
Spleen  
 The spleen was very active with regards to cytokine activity. IL-1β and IFN-γ 
were significantly downregulated in the positive birds, -3.52 and -4.52 fold. On the 
contrary, expression of CCL5 and OASL were increased, 7.15 and 64.84 fold. Both the 
clinical and sub-clinical groups had significantly decreased levels of IL-β, -3.16 and -
3.44 fold when compared to the control group. IL-6 in the clinical group was considered 
to be different than the expression seen in the sub-clinical group, 0.67 and -14.95 fold. 
CCL5 was significantly upregulated from the controls in the clinically affected and 
considered statistically different than the sub-clinically affected, 9.49 and 4.81 fold. 
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Expression of IFN-γ was decreased in both the clinical and sub-clinical groups, -5.24 
and -3.8 fold. Mx was slightly upregulated in the clinically affected, 6.43 fold, and 
considered to be different than the sub-clinical that were slightly downregulated, -6.52 
fold. OASL was significantly upregulated in the clinically affected group. Unlike the 
sub-clinical group which showed an increase in FasL, 5.58 fold, the clinically affected 
group showed a decrease in FasL, -3.06 fold. See figures 19-21. 
 
 
Figure 39. Gene expression in the spleen of positive birds. “*” denotes significant 
differencec from controls. P-values <0.05 were considered to be significant.  
 
   
* 
* * 
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Figure 40. Cytokine and chemokine gene expression in the spleen vs. clinical status. 
“*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
 
 
 
 
*a 
b 
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Figure 41. Antiviral, signaling, and apoptotic gene expression in the spleen vs. 
clinical status. “*” denotes significant difference from controls. “a/b” denotes 
significant difference between clinical and sub-clinical groups. P-values <0.05 were 
considered to be significant. 
 
 
Trachea  
 No IL-10 data were acquired for the trachea. Like the spleen, the trachea was 
another very active tissue with regards to changes in cytokine gene expression. IL-6 and 
IL-1β were significantly downregulated in the positive group, -1.78 and -2.22 fold 
respectively. CCL5 was upregulated 11.18 fold. Both IFIH1 and IFN-γ were 
significantly downregulated, -1.93 and -4.98 fold while OASL was upregulated 35.47 
fold. Both IL-1β and IL-6 were upregulated in both the clinically, -3.2 and -1.7 fold, and 
sub-clinically, -1.56 and -1.77 fold, affected groups. CCL5 was significantly upregulated 
a 
b 
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in the clinically affected birds, 15.28 fold, from the controls and considered statistically 
different than the sub-clinical group at 7.08 fold, which was also different than the 
controls. There was a lot of antiviral activity in the trachea. Expression of IFIH1 and 
IFN-γ was decreased in both the clinical, -1.70 and -5.6 fold, and sub-clinical groups, -
2.15 and -4.35 fold. Additionally, OASL was upregulated in both of the groups and 
considered to be different from each other. The clinical group expressed OASL at 47.78 
fold while the sub-clinical expressed OASL at 23.15 fold. See figures 22-24.    
 
 
Figure 42. Gene expression in the trachea of positive birds. “*” denotes significant 
difference from controls. P-values <0.05 were considered to be significant.  
 
* 
* * * * 
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Figure 43. Cytokine and chemokine gene expression in the trachea vs. clinical 
status. “*” denotes significant difference from controls. “a/b” denotes significant 
difference between clinical and sub-clinical groups. P-values <0.05 were considered 
to be significant. 
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Figure 44. Antiviral, signaling, and apoptotic gene expression in the trachea vs. 
clinical status. “*” denotes significant difference from controls. “a/b” denotes 
significant difference between clinical and sub-clinical groups. P-values <0.05 were 
considered to be significant. 
 
 
Gene Regulation by Positive Status 
Pro/Anti-Inflammatory Cytokine and Chemokine Expression 
 IL-1β was significantly upregulated in the heart but down regulated in the spleen 
and trachea. IL-6 was upregulated in the brain and heart however downregulated in the 
trachea. There were no differences detected in IL-10 between the positive birds and 
negative control birds. CCL-5 was upregulated in the brain, GI, spleen, and trachea. The 
* * * * 
*a 
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spleen and trachea were the most active tissues. CCL-5 was the most active gene in this 
group of cytokines and chemokines. See Figure 61.  
 
Signaling, Antiviral, and Apoptotic Gene Expression      
 IFIH1 was upregulated in the heart and liver but downregulated in the trachea of 
the positive birds. IFN-γ was downregulated in the GI, liver, lung, spleen, and trachea. 
Mx was only upregulated in the brain while OASL was upregulated in the GI, liver, 
spleen, and trachea. Expression of neither of the death ligands, TRAIL or FasL, were 
significantly different in the positive group compared to the negative controls. IFN-γ, 
and OASL were the most active in this group of signaling, antiviral, and apoptotic genes. 
(Figure 25).  
  
Figure 45. Heat map of gene regulation by positive status. Red indicates significant 
upregulation and blue indicates significant downregulation. P values <0.05 are 
considered significant.  
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Immune Evasion  
 Based on the cytokine profile of the positive birds, the particular H5N2 virus 
involved in the outbreak was very efficient at evading the turkey’s immune response. It 
appears that the virus was able to avoid the host’s detection immediately upon exposure. 
The virus was able to avoid detection and suppress any immune reaction in the trachea 
by downregulating IFIH1 and IFN-γ, thus allowing the virus to move quickly beyond the 
trachea. Furthermore, IFN-γ was downregulated in the GI, liver, lung, and spleen thus 
disabling the turkey’s ability to fight off the infection. The NS1 protein has been shown 
to limit the production and effectiveness of the interferons, (Hale et al., 2010), by 
blocking the cytoplasmic RIG-I/MDA5 signaling cascade or by attenuating INF-
inducible signaling (Hale et al., 2010; Vijayakumar et al., 2015). This may be a potential 
mechanism for downregulating IFN-γ. Although IFN-α and IFN-β were not successfully 
measured, it is possible that their activity can be indirectly measured by the IFN induced 
antiviral proteins (Ewald et al., 2011), Mx and OASL. Mx was upregulated in the brain 
and OASL was upregulated in the GI, liver, spleen, and trachea indicating increased IFN 
activity.  
 
The lack of upregulation of IL-1β, except in the heart where there were 
pathological lesions, and downregulation in the spleen and trachea indicates an induced 
lack of inflammatory response. While there was an upregulation of the 
chemokine/secondary pro-inflammatory mediator, CCL-5, in the brain, GI, spleen, and 
trachea, it was a secondary response to the presence of the virus in the tissue and 
 91 
 
insufficient response. The upregulation of IL-6 in the brain and heart was expected given 
the neurological and pathological lesions observed at tissue collection. Although the 
changes in the gene expression of TRAIL, due to high variability, were not statistically 
significant, the average of TRAIL was always greatly negative, indicating that an 
induced decrease in apoptosis was possible. The NS 1 protein has been shown to the 
ability to suppress ligand-mediated apoptosis to increase infectivity in chickens (Xing et 
al., 2009).  
 
Gene Regulation by Clinical Status 
Pro/Anti-Inflammatory Cytokine and Chemokine Expression 
IL1-β was upregulated in the lung of the sub-clinical and downregulated in the 
spleen and trachea of both the clinical and sub-clinical groups. IL-6 was up in the brain 
of the clinical, heart of both groups, liver of clinical, and down in the spleen of the sub-
clinical and trachea of both groups. CCL-5 was up in all tissues of both groups except in 
the clinical lung, and sub-clinical GI and liver. CXCLi-2 expression was increased only 
in the lung of the sub-clinical.  
   
Signaling, Antiviral, and Apoptotic Gene Expression      
 IFIH1 was up in the heart and liver of the clinical and decreased in the trachea of 
both groups. INF-γ was downregulated in the liver, lung, spleen, and trachea of both 
groups as well as in the GI of the clinical. Expression was significantly lower in the liver 
and lung of the clinically affected. A very different phenomenon was seen in the brain, 
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IFN-γ production was upregulated in the sub-clinical yet downregulated in the clinical. 
This potentially explains the neurological signs and increased viral load in the clinically 
affected noted in a previous trial. Mx was upregulated in the GI and spleen of the clinical 
and downregulated in both tissues in the sub-clinical. OASL expression was 
significantly upregulated in all tissues except in the sub-clinical brain, GI, and spleen 
and clinical lung. The upregulation in the heart and trachea was much greater in the 
clinically affected. OASL is known to aid in the prevention of tissue damage and hyper-
inflammatory response and consequently its wide spread upregulation may have 
contributed to the virus’ pathogenesis and immune evasion as indicated by the higher 
levels in the clinically affected turkeys. There was little significant apoptotic gene 
expression. FasL was upregulated in the sub-clinical livers and spleen while being down 
in the clinical spleen. (Figure 26.)   
 
While there were differences noted between the clinical and sub-clinical birds 
that may explain clinical status and viral load differences, the overall cytokine response 
difference between the 2 groups is not that remarkable. It is likely that the sub-clinical 
birds were able to restrict virus replication more effectively than the clinical birds, but all 
sub-clinical birds were positive and the virus was widespread. Considering the extensive 
viral presence in all of the tissues, viral loads, and cytokine profile, the sub-clinically 
affected were most likely only prolonging the inevitable deadly outcome.   
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Figure 46. Heat map of gene expression changes by clinical status. Red indicates a 
significant upregulation, blue a significant downregulation, and yellow indicates no 
change from the controls. P values <0.05 were considered significant. 
 
 
 Conclusion 
While there was some pro-inflammatory response it was not in excess. There is 
no evidence of a cytokine storm. Death was rather from a lack of a response. This 
particular virus was very efficient in evading the turkey’s immune response. It was able 
to avoid initial detection by suppressing the expression of viral detecting mechanisms, 
pro-inflammatory cytokines, and antiviral components in the trachea. Undetected the 
virus was able to quickly spread throughout the body and replicate very rapidly.  The 
system wide downregulation of IFN-γ and upregulation of CCL-5 and OASL contributed 
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to the pathogenesis. Death appears to be from organ failure due to viral overload not a 
cytokine storm.   
 
Both the clinically and sub-clinically affected turkeys had virus in all of the 
tissues. The clinical differences are most likely the result of viral load in the various 
tissues, particularly in the brain and spleen. The virus was very efficient at evading 
detection and, as a consequence, immune defense mechanisms. Some birds were more 
effective than others in restricting viral replication, hence the differences in viral load of 
the tissues and subsequent clinical status. Given the system-wide viral distribution and 
load, the sub-clinical birds were most likely delaying the inevitable fatal outcome.   
 
In general, information regarding HPAIs in experimentally infected turkeys is 
minimal and information detailing the response of naturally infected turkeys does not 
exist. Field data from naturally infected turkeys is essential for describing and 
understanding the disease during an outbreak. Information acquired under experimental 
conditions cannot be directly equated to what is seen under natural conditions, as route 
of exposure and environment are not comparable. This study is novel and the first of its 
kind.  
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CHAPTER IV                                                                                                
CONCLUSIONS 
 
The outbreak of the highly pathogenic avian influenza virus (HPAI) in 2014- 
2015 was by far the largest animal disease outbreak in United States history. The turkey 
industry was the most affected, nearly 70% of the confirmed cases were in turkeys. 
Despite the massive devastation it caused, very little was known about the specific virus, 
particularly regarding its distribution and lesions caused within the turkey host during 
the outbreak. It was unknown as to why there was a very small population of turkeys that 
would survive the massive mortality and appear unaffected several days later. Some 
speculated they were perhaps “resistant” to the infection.  
 
All of the birds in the infected barn were infected regardless of clinical status. 
However, the viral load in the tissues was different in the clinically affected versus sub-
clinically affected turkeys. The viral load was higher in the brain, GI, spleen, and trachea 
of the clinically affected birds. The increased viral concentration in the brain most likely 
contributed to the neurological symptoms observed upon tissue collection. Histological 
viral lesions were in general very mild and insignificant. The majority of the histological 
changes were confined to the trachea and liver in the clinically positive birds and 
primarily consisted of the infiltration of small numbers of heterophils, lymphocytes, and 
macrophages. This study is the first of its kind that provides virus distribution and semi-
quantitative matrix gene analysis across multiple tissues in the turkey. It is also the first 
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of its kind that characterizes the differences in distribution and matrix gene levels 
between clinical and sub-clinical birds. The virus appeared to replicate more rapidly in 
the clinically affected birds, particularly in the brain and reproductive tracts.  
 
There was some pro-inflammatory response noted but it was not in excess. Death 
does not appear to be the result of a cytokine storm or host response but rather from a 
lack of response. This particular virus was very efficient in evading the turkey’s immune 
response. It was able to avoid initial detection by suppressing the expression of viral 
detecting mechanisms, pro-inflammatory cytokines, and antiviral components in the 
trachea. Undetected the virus was able to quickly spread throughout the body and 
replicate very rapidly.  The system wide downregulation of IFN-γ and upregulation of 
CCL-5 and OASL contributed to the pathogenesis. Death appears to be purely from viral 
load in the tissues and subsequent interference with basic physiological functions and 
not a cytokine storm.  While there were differences noted between the clinical and sub-
clinical birds that may explain clinical status and viral load differences, the overall 
cytokine response difference between the 2 groups is not that remarkable. It is very 
likely that the sub-clinical birds were able to restrict virus replication more effectively 
than the clinical birds, but all sub-clinical birds were positive and the virus was 
widespread. Considering the extensive viral presence in all of the tissues, viral loads, and 
cytokine profile, the sub-clinically affected were most likely only prolonging the 
inevitable deadly outcome. 
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Virus was detected in all of the tissues collected on the positive premise, 
regardless of clinical status thus illustrating its extreme pathogenesis. Generally, 
histological lesions were minimal and cytokine responses were not in excess. Death does 
not appear to be the result of organ damage/necrosis or even cytokine storm but purely 
from immune evasion and excessive viral load in the tissues. Consequently, the high 
viral loads resulted in organ failure. 
 
Future Research 
 The results of the trials prompted additional questions that need to be further 
studied and explained. One of the biggest questions that has yet to be answered is with 
regards to the exact location of the virus in the tissues. Virus was detected in all of the 
tissues that were collected yet, minimal pathological and histological lesions were seen. 
With the help of immunohistochemistry, the exact location of the virus can be located 
and possibly provide even further insight into the virus and its pathogenesis. In addition, 
it is unknown as to whether there were any genetic differences between the clinical and 
sub-clinical birds that may account for the different clinical statuses or susceptibility 
seen, such as variants of the Mx gene previously described in the chicken (Ewald et al., 
2011).  
 
It would be advantageous to further characterize the virulence factors of this 
particular H5N2 virus and compare it to viruses from other outbreaks. Due to the rapid 
spread of the disease, it is unlikely that antibodies had time to develop but that avenue 
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should be explored. Other aspects of the humoral response and characteristics of 
circulating blood such as viral load have yet to be investigated.  
 
Turkey research is lacking in general due to the cost, time, and equipment 
required to conduct such research. To my knowledge, there are no published data that 
describe the changes in gene expression and the dissemination of an HPAI virus in a 
naturally infected turkey flock.  This trial is the first of its kind, therefore there is much 
more to be explored.  
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